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EXPLANATORY  MEMORANDUM 
I.  GENERAL  FRAMEWORK 
This  proposal  for  a  directive  has  been  prepared  In  the 
context  of  the  White  Paper  on  completing  the  internal 
market,  the  work  programme  of  which  provides  for 
harmonization  of  the  laws  relating  to  electro-medical 
equipment. 
In  this  context,  the  Counci I  adopted  a  first  directive 
relating  to  active  implantable  medical  devices 
(Directive  90/385/EEC)  on  20  June  1990.  With  the  adoption 
of  this  directive,  a  preponderant  part  of  the  field  of 
medical  devices  wi  I I  be  covered  by  harmonized  laws. 
However,  medical  devices  i~tended  for  ln  vitro  diagnosis  are 
not  included  in  the  scope  of  this  proposal.  These  products 
wl  I I  be  dealt  with,  in  view  of  their  particular  nature,  in  a 
specific  di~ective. 
Before  starting  on  the  preparation  of  its  proposal.  the 
Commission  examined  the  regulations  relating  to  the  medical 
devices  sector.  The  results  of  this  examination  confirmed 
that  there  are  considerable  differences  between  the  Member 
States  as  regards  both  the  technical  design  and  production 
requirements  and  the  administrative  procedures  for  the 
examination,  testing,  inspection  and  authorization  for 
marketing,  and  the  putting  into  service  and  after-sales 
survei I lance  of  medical  devices. 
The  current  legislative  situation  in  the  Member  States  is 
characterized  by  a  marked  lack  of  uniformity  if  the  various 
national  laws  are  compared  with  regard  to  their  scope  and 
the  kind  of  risks  covered.  A  large  number  of  specific  laws 
cover  certain  groups  of  products  such  as  electro-medical 
equipment,  disposable  products,  equipment  for  the  disabled,-
sterile products,  and  even  specific  products.  In  several 
Member  States,  a  range  of  medical  devices  (in  particular  in 
the  field  of  sterile  and  disposable  products)  are  covered, 
in  the  absence  of  specific  l~ws,  by  the  regulations  on 
medicinal  products.  The  fact  that  medical  equipment,  which 
.as  a  general  rule  acts  physically,  is  sometimes  treated  the 
same  as  medicinal  products,  which  act  pharmacologically,  has 
led  in  several  cases  to  technical  barriers. - 3  -
With  the  regard  to  the  means  of  ~ontrol  ~sed to  ensure  the 
safety  and  health  protection  of  patients  and  users,  two 
different  approaches  were  found  In  the  Community.  A  large 
number  of  the  Member  States  apply  systems  based  on  the 
Inspection  of  products  before  they  are  placed  on  .the  market 
by· means  of  type-examinations  or  approval  systems,  while 
others  ask  companies  to  apply  good  manufacturing  practices. 
Where  the  devices  are  subject  to  the  rules  on  medicinal 
products,  both  product  certification  and  authorization 
procedures  for  companies  apply. 
The  information  obtained  pursuant  to  Directive  83/189/EEC 
laying  down  an  information  procedure  in  the  field  of 
techn.ical  regulations  confirms  the  lack  of.uniformity  in  the 
legislative  approach  taken  with  regard  to  medical  devices. 
Between  1988  and  1990,  some  25  sets  of  draft  ~atlonal 
regulations,  most  of  them  relating  to  spec1fic  products, 
were  notified  to  the  Commission. 
Lastly,  it  should  be  said  that  some  of  the  Member  States  are 
aware  of  the  unsatisfactory  situation  and  haVe  indicated 
their  desire  to  establish  an  overall  legal  framework  for  the 
medical  devices  field. 
In  view  of  the  differences  in  approach,  whLch  by  their 
nature  are  inco.mpatible  with  a  single  Community  market  in 
medical  devices,  it  is  essential  to  set  up  a  Community 
system  of  laws  based  on  Article  100a  of  the  EEC  Treaty  to 
abolish  and  prevent  technical  barriers  to  trade. 
The  aim  of  this  directive,  therefore,  is  to  ensure  the 
safety  and  health  protection  of  patients  and  users  by  means 
of  a  uniform  sectoral  approach  and  to  create  an  appropriate, 
suitable  framework  for  the  technological  development  of  the 
products  concerned. 
The  medical  devices  sector  is  a  large  market:  world 
consumption  of  these  products  in  1990  has  been  put  at 
E  C  U  54 . 1  b i I I i on ,  i n c I u d i n g  E  C  U  2 3· . 1  b i I I i on  i n  t he  US A  a ( 1 
ECU- 1.2  US$)  and  ECU  15.0  billion  in  the  Community 
(source:  Health  Industry  Manufacturers  Association  (HIMA)). 
The  Community  share  of  world  production  has  been  calculated 
to  be  ECU  16.1  bi II ion  (USA:  25.7- Japan:  8.0).  Between 
1986  and  1989,  the  annual  avera~e growth  In  consumption  was 
9.5%  {USA:  9.9%- Japan:  8.6%).  The  number  of  jobs  In  this 
branch  of  industry  within  the  Community  totalled over 
200  000  in  1990. 
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In  view  of  the  rapid  speed  of  innovation  in  this sector, 
Community  legislation  will  provide  an  appropriate  framework 
which  wi  I I  help  to  maint~in and  to  promote  this  favoutable 
development. 
The  proposal  for  a  directive  has  been  designed  and  · 
structured,  as  regards  technical  reQuirements.  In  the  1 ight 
of  the  Counci I  Resolution. of  7  May  1985  on  a  new  approach  to 
technical  harmonization  ani standardization  The 
legislators  already  appl led  the  principles  set  out  In· the 
abovementioned  Resolution  with  the  adoption  of  Councl I 
Directive  90/~85/EEC of  20  June  1990  relating  to. active 
Implantable  medical. devices.  This  proposal  therefore 
includes  what  has  been  achieved  with  that  D·irectlve  and 
transposes  it  to  the  medical  devices  which  it  covers. 
The  implementation  of  the  conc~pt  of  reference  to  standards 
will  be  facilitated  by  the  fact  that  some  of  the  harmonized 
European  standards,  in  particular  those  of  a  horizontal 
nature,  wi  II  already  be  avai table  from  the  application  of 
the  Directive  relating  to  active  Implantable  medical 
devices.  Furthermore,  important  work  on  the  establ ishmeMt  of 
a  sectoral  system  of  harmonized  standards  has  already  been 
started  by  CEN/CENELEC. 
The· part  of  the  directive  relating  to  procedures· for  the 
assessment  of  conformity  is  based  on  the  modula·r  approach 
set  out  in  Counci I  Decision  90/683/EEC  of  13  December  1990 
The  approach  followed  with  regard  to  the  assessment  of 
conformity  enables  a  distinction· to  be  made  with  regard  to 
verifications  carried· out  by  a  third  party  according  to  the 
nature.of  the  potential  risk  inherent  in  medical  devices. 
For  this  reason  and  In  view  of  the  diversity  of  products 
concerned,  the  devices  covered  by  the  directive  have  been 
dlvl.ded  into  four  classes  for  the  purpose  of  assessment 
procedures. 
The  intervention  of  the  certification  bodies  (notified 
bodies)  has  been  graded.  For  devices  in  Class  I,  conformity 
is  established  as  a  general  rule  under  the  responsibility 
of  the  manufacturer  alone.  Class  lla  devices  require,  in 
view  of  the  risks  more  closely  associated  with  manufacture, 
the  intervention  of  a  notified  body  with  regard  to  the 
manufacture  stage.  For  devices  in  Classes  lib  and  Ill,  on 
the  other  hand,  verification  by  a  notified  body  Is 
necessary  with  r~gard to  design  and  the  manufacturing 
st·age.  Furthermore,  Class  Ill  devices  which  are  critical 
devices  should,  as  a  general  rule,  undergo  a  cl lnlcal 
evaluation  under  the  responsibi I ity  of  the  manufacturer. 
The  conformity  of  their  design  mu~t  be  explicitly  certi11ed 
by  a  notified  body  befote  they  are  placed  on  the  market. 
(1 >  uJ  No  C 1 36,  4. 6. 1985,  p.  1 . 
(l)  OJ  No  L 189,  20.7.1990,  p.  17. 
(3)  OJ  No  L 380,  31.12.1990,  p.  13. - 5  -
II.  CONTENTS  OF  THE  PROPOSAL 
1.  Article 1- Scope 
Several  definitions,  In  particular  those  of  a  Amedlcal 
device",  a  "custom-made  device"  and  a  "device  Intended  for 
clinical  Investigation"  have  been  taken  from  the  Directive 
relating  to  active  Implantable  medical  devices.  Since  the 
scope  of  this  proposal  is  broader  than  that  of  the 
abovementioned  Directive,  a  few  slight  amendments  have 
therefore  been  made. 
The  term  "medical  device"  means  products  the  function  of 
which  is  solely  or  principally  medical.  A series  of  products 
whose  function  is  not  essent i a I I y  medIca I  are  therefore 
excluded  from  the  scope,  even  if  these  products  may  be  used 
to  prevent  disease  or  alleviate  a  handicap,  e.g.  cosmetic 
products,  multiple-use  data-processing  eQuipment. 
The  medical  function  of  a  medical  device  may  be  fulfilled 
either  by  means  of  a  product  used  on  Its  own  or  as  the 
result  of  the  combination  of  several  products,  e.g. 
dlsposabl~  tubings  combined  with  an  infusion  pump.· 
The  criterion  for  the  distinction  between  a  medical  device 
and  a  medicinal  product.is  the  principal  action  produced.  A 
product  which  achieves  Its  principal  action  by 
pharmacological,  immunological  or  metabolic  means  Is  not 
considered. to  be  a  medical  device.  However,  a  medical  device 
may  include  a  medicinal  substance  as  an  integral  part  in 
order  to·increase  its  effectiveness,  e.g.  a  heparin-coated 
catheter. 
Where  the  action  produced  by  the  presence  of  the  medicinal 
substance  is  secondary  to  the  principal  action  of  the 
devtce,  the  conformity  assessment  procedure  for  authorizing 
t he · p I a c· i n g  o f  t he  p r od  u c t  con c e r ned  on  t h e  m  a r lc e t  I s 
covered  by  this  proposal  for  a  directive.  As  far  as  safety 
aspects  concerning  the  presence  of  the  substance  are 
concerned,  the  verifications  reQuired  are  carried out,  where 
appropriate,  by  analogy  to  the  methods  contained  In 
Directive  75/318/EEC. - 6  -
On  the  other  hand,  where  a  device  is  Intended  to  administer 
a  medlcin~l  product  ~nd therefore  constitutes·a  cont~iner 
for  that  product,  e.g.  a  pre-fi lied  syringe,  the  aspects· 
relating  to  the  safety  of  the  device  are  covered  by  this 
'proposal,  wh•le  the  placing  of  the  medicinal  product  on  the 
market  Is  subJect  to  the  Community  legislation  relating  to 
medicinal  products  (see  Article  1,  para.  3). 
The  key  legal  definitions  Include  definitions  of  "placing  on 
the  market"  and  the  "manufacturer".  The  "placing  on  the 
market"  means  the  physical  transfer  of  a  medical  device  from 
the  manufacturer  or  a  person  authorized  by  him  to  the 
distributor  or  user.  Placing  on  the  market  must  not  be 
confused  with  the  fight,  under  the  directive,  to  market 
medical  devices, in  the  European  Community.  The  defin!tlon  of 
the  manufacturer  is  useful  in  order  to  be  able  to  determine 
the  natural  or  legal  persons  subject  in  particular  to  the 
conformity  asse~sment  procedures  (Article  10). 
The  scope  of  this  propo~~~  lricludes  medical  devices  which 
emit  ionizing  radiation.  It  therefore  specifies  the· 
requirements  relating  to  the  design  and  manufactur~ of  the 
equipment  concerned  and  the  conformity  assessment 
,procedures.  The  dire~tive does  not~  however,  affect  the 
authorization  required  under  oirebtive  80/836/Euratom  for 
the  putting  into  service  and  use  of  such  equipment. 
2.  Articles  2  and  3 
These  are  conventional  Articles  based  on  the  new  approach 
relating  to  placing  on  the  market,  putting  into  service  and 
essential  requirements. 
3.  Article 4- Free  movement.  devices  Intended  for  special 
purposes 
In  addition  to  the  conventional  clause  concerning  free 
movement,  this  Article  refers  to  devices  intended  for 
special  purposes,  i.e.  devices  intended  for  clinical 
investigation  and  custom-made  devices. 
Devices  intended  for  clinical  investigation  are  made 
avai table  to  medical  practitioners  when  total  compl lance 
with  the  essential  requirements still  has  to  be  established 
so  that  the  device  can  undergo  an  assessment  of  conformity 
procedure.  The  carrying  out  of  clinical  lnve~t igat Ions 
specifically  makes  it  possible  to  confirm  conformity  with 
the  relevant  essential  requirements.  such  devices  therefore 
do  not  bear  the  CE  marie. 
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Custom-made  devices  are  made  in  accordance  with  the 
prescription  of  a  medical  specialist  or  any  other  ~uthorlzed 
person  giving  the  specific  design  characteristics of  the 
device  concerned.  Compl lance  with  the  requirements  of  the 
directive  Is  therefore  established  under  the  Joint 
responsibility  of  the  manufacturer  and  the  person  Issuing 
the  prescription  and  this  Is  why  such  devices  do  not  have  to 
bear  the  CE  mark. 
4.  Article 5- Reference  to  standards 
The  reference  to. harmonized  standards  clause  Is  based  on  the 
Counci I  Resolution  of  7  May  1985 . 
.. 
By  means  of  the  reference  to  certain  monographs  of  th~ 
European  Pharmacopoeia  in  paragraph  2,  the  Community  Is 
discharging  the  obi igat ions  incumbent  on  the  Member  States 
pursuant  to  the  Convention  of  22  July  1964  on  the 
preparation  of  a  European  Pharmacopoeia. 
In  the  field  of  the  medical  devices  covered  by  this 
proposal,  the  European  Pharmacopoeia  has  prepared  several 
monographs  relating  in•particutar  to  sutures  and  the 
Interaction  between  cert~in·materiats used  for  devices  and 
medicinal  products.  SubJect  to  Article  5,  paragraph  2,  these 
monographs  wi  I I  have  the  same  status,  under  this  proposal, 
as  harmonized  standards.  The  appl icatlon  of  the  monographs 
wi  I I  therefore  remain  volu~tary. 
The  Commission  has  proposed  to  the  CEN  and  the  European 
Pharmacopoeia  the  conclusion  of  a  memorandum  of 
understanding  to  determine  the  respective  fields  of  activity 
and  to  establish  collaboration  in  areas  of  common  Interest. 
5.  Articles  6  and  7.- Committees 
Regardless  of  the  conventional  role  of  the  Committee  set  up 
under  Directive  83/189/EEC  (cf.  Article  5(3)),  the  field  of 
activity  of  the  Advisory  Committee  set  up  under  Directive 
90/385/EEC  has  been  extended  to  the  sector  covered  by  the 
proposal.  Any  matter  relating  to  the  implementation  and 
practical  application  of  the  Directive  may  be  brought  before 
this  Committee .. - 8  -
W  I t h . r ega r d .. t o  t he  c I a s s i f i c a t  i. on  o f  me d i c a I  de v I c e s  . I n t o 
.four  classes of  products  (see  Articles  8  and  12),  regulatory 
measures  have  to  be  laid  down  at  Community  level  f~r  the 
products  concerned.  In  view  of  the  nature  of .these.measures 
and  the  6onsequences  as  regards .the  leveJ  6f  intervention  of 
third  parties,  the  measures  should  be  adopted  ln. accordance 
with  the  "Regulatory  Committe~"  procedure  (variant  I I Ia  of 
Co~ncl I  Decision  87/373/EEC  of  13  July  1987  laying  ~Dw~  the 
procedures  for  the  exercise  of  implementing  powers  conferred 
on  the  Commission). 
6.  Article  8- Safeguard  clause 
This  Article  is  based  on  the  Council  Resolut.ion  of 
7  M~y  1985  concerning  the  new  ap~roach. 
7.  Articles  9  and 13- Classification 
Medical  dev;ces  are  divided  into  four  product  classes  in 
order  to  be  able. to  decide  on  the  appropriate  level,of 
Intervention  by  the  notified  b~dies.  The· classification 
rules  set  out  in  Annex  9  enabJ~"m•nufactujers  to  classify 
the.ir  products  ~ccording to  the  relevant  class.  Where  there 
is  doubt,  manufacturers  may  contact  the  competent· 
authorities  which,  for  their  part,  may,  if  necessary, 
initiate  the  Community  decision-making  process~ 
Decisions  may  have  to  be  taken  with  regard  to  the 
classification of  medical  device.s  in  particular. where: 
the  classification  rules  and  the  Commission  guidelines  do 
no t  en a b 1 e  a  s t r a i g h t f.o r w  a r d  c I a s s I f i c a t i on · t o.  be  m  a de ; 
the  experience  obtained  with  specific  fami I ies  of. 
products  justifies  a  reclassification  by  way  of 
~erogation  from  the  classification  rules;. 
the  classification  rules  need  to  be  adjusted  in  the  I ight 
of  te~hnical  development  and/or  experience.with  given 
devices. - 9  -
8.  Article 10- Information  on  lncid.ents  occurring  following 
placing  of  devices  on  the  market 
This  Article  sets  up  a  Community  warning  system  regarding 
Incidents  occurring  with  devices  already  placed  on  the 
market.  This  system  wl  I I  enable  the  Member  States  to  take 
appropriate  measures  early  on  where  an  incident  suggests 
that,  because  of  a  design  or  manufacturing  fault,  a  device 
may  seriously  damage  the  health  of  patients  or  users. 
The  obligations  on  manufacturers  to  notify  certain  Incidents 
are  set  out  in  Annex  2,  point  3.1,_  Annex  4,  point  3,  Annex 
5,  point  3.1,  and  Annex  6,  point  3.1.  Each  Member  State  must 
set  up  a  central  unit  to  record  and  eva~uate  the  repoits 
obtained.  Where  measures  have  to  be  taken  by  the  national 
authorities,  th~ Member  State  concerned  must  Inform  the 
other  Member  States  and  the  Commission. 
9.  Article  11.  Annexes  2  to 7- Conformity  assessment 
procedures 
Suitable  conformity  assessment  procedures  have  been  selected 
from  among  those  adopted  in  Counci I  Decision  90/683/EEC  of 
13  December  1990  and  supplemented  according  to  sectoral 
requirements.  The  minor  additions  made  refer  in  particular 
to  the  documentation  required,  the  safety  of  combined 
devices,  s.ter i llzat ion  procedures  and  clinical  data.  The 
f o I I ow i n g  p r o c e d u r e s  a p p I y  t o  t he  f o u r  c I a s s e' s  o f  de v i c e s : 
Class  I 
Class  lla 
the  manufacturer  alone  is  responsible  for  the 
assessment  of  conformity  (module  A of  Counci I 
Decision  90/683/EEC} 
the  manufacturer  himself  is  responsible  for 
assessing  the  product  design.  The 
intervention  of  a  notified  body  is  required 
at  the  production  stage  (module  A  combined 
with  either  modules  D,  E  or  F).  Furthermore, 
the  manufacturer  may  opt  for  full  qua 1 i ty 
assurance  (module  H),  although  the  procedure 
specified  In  that  module  is  more  restrictive 
than  those  mentioned  above. (3) 
Class  I lb 
Class  I I I 
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the  design  and  manufacture  of  the  product 
must  be  referred  to  a  notified  body.  The 
manufacturer  may  follow  either  the  full 
quality  assurance  procedure  <module  H)  or 
submit  a  prototype  for  type-examination 
(module  8).  In  the  case  of  the  latter.  the 
manufacturer. must  also  apply  one  of  the 
procedures  referred  to  in  modules  D,  E  or  F. 
the  procedures  are  broadly  the  same  as  those 
set  out  for  Class  lib.  However,  If  full 
quality  assurance  Is  applied  (module  H)  the 
file  relating  to  the  product  design  must  be 
examined.  Furthermore,  regardless  of  the 
procedure  followed  the_  design  file  must  as  a 
general  rule  include  an  assessment  of 
conformity  based  on  clinical  data  (see 
Annex  10,  point  1.1). 
The  manufacturers'  choice  of  several  procedures  w111·  make  It 
possible  to  select  the  most  appropriate  procedure  taking 
account  in  particular  of  the  pre-existing  regulatory  system 
and  the  nature  and  size  of  the  company. 
10.  Article 12- AssemblY  and  sterilization 
This  Article  refers  to  assembly  and  steri I ization  activities 
carried  out  commercially.  It  applies  to  devices  already 
bearing  the  CE  mark.  The  person  Who  carries  out  the 
activities  concerned  Is  not  considered  to  be  the 
manufacturer  as  legally  defined  where  the  activities  are 
carried  out  in  accordance  with  the  manufacturer's 
instructions. 
If,  however.  assembly  and  sterilization  go  beyond  the  limits 
laid  down  by  the  manufacturer  of  the  devices,  they  are 
specific  manufacturing  activities  which  are  then  subject  to 
the  procedures  set  out  in  Article  10. 
The  procedures  referred  to  in  Article  11  apply  regardless  of 
the  classification  of  the  device. - 11  -
11.  Article 14  -Registration of  persons  responsible  for  placing 
devices  on  the  market 
This  Article  applies  to  devices  which  are  not  subject  to 
inspection  by  a  notified  body  before  being  placed  on  the 
market.  These  are  the  Class  I  devices  and  custom-made 
devices.  For  these  devices,  the  manufacturer  or  person(s) 
responsible  for  placing  them  on  the  market  must  Inform  the 
competent  authorities  of  the  address  of  their  registered 
place  of  business  and  the  category  of  devices  concerned. 
This  notification  enables  the  Member  States  to  have  better 
control  of  the  devices  in  Question  which  are  marketed  in 
their  territory  and,  if  necessary,  to  take  appropriate 
measures. 
12~  Article  15  - Clinical  investigation 
Clinical  investigations  may  be  necessary  in  order  to  confirm 
that  a  device  fully  complies  with  the  essential 
reQuirements.  The  competent  authorities  of  each  Member  State 
in  which. the  investigations  are  carried  out  must  be  able  to 
i n t e r v e n e· ,  i f  n e c e s s a r y ,  t o  p r o t e c t  t h e  h e a I t h  o f  p a t  i e n t s 
and  pub I i c  o r de r .  A  r t i c I e  1 4 ,  p a r a g r a ph  2 •.  1 a y s  down  a  t a c i t 
approval  procedure  for  implantable  and  other  devices  in 
Class  I I l. 
The  right  of  intervention  of  the  competent  authorities  is 
c e n t r e d  on·  con s I de r a t i on s  o f  pub I i c  h  e a I t h  and  pub 1 i c  o r de r . 
For  this  reason,  intervention  by  the  authorities  does  not 
include  a  preliminary  evaluation  of  other  aspects  which  are 
the  subject  of  the  conformity  assessment  procedures.  The 
role  of  an  ethics  committee  in  this  context  is  to  evaluate 
the  acceptability  of  the  plan  of  investigations  from  the 
viewpoint  of  patient  health  and  ethical  considerations. 
The  competent  authorities  are  not  bound  by  the  opinion 
expressed  by  an  ethics  committee.  However,  such  an  opinion 
may  make  it  easier  for  them  to  examine  the  file. 
13.  Articles  16  to  19  - Notified  bodies,  EC  mark 
These  are  Articles  typical  of  the  new  approach  directives. - 12  - 0 
14.  Article 20- Confidentiality 
The  observance  of  confidentiality  Is  essential  for  the 
protection  of  specific  data  and  because  of  the  economic 
Impact  of  the  procedure~ for  the  parti~s concerned. 
15.  Article  21  - Guide! ines 
The  documents  referred  to  in  the  ~uidel ines  are  based  on  the 
practice  followed  with  regard  to  medicinal  products  as  set 
out  In  Directive  89/341/EEC.  The  guide I ines  may  provide 
useful  information  for  the  application  of  the  directive, 
a I though  they  do  not  themse I ves  have .any  I ega I  force.  They 
wi  II  cover  aspects  that  are  not  dealt  with  in  harmonized 
standards. 
16.  Article  22- Repeal  and  amendment  of  Directives 
Directive  76/764/EEC  covers  mercury-in-glass  thermometers. 
It  is. an  optional  Directive.  The  products  and  features 
concerned  are  covered  by  the  scope  of  this  directive. 
The  amendment  of  Directive  84/539/EEC  restricts  Its  scope  to 
electro-medical  eQuipment  used  in  veterinary  medicine. 
EQuipment  used  in  human  medicine  is  covered  by  this 
proposal. 
The  purpose  of  amending  Directive  90/385/EEC  is  to  add  to 
that  Directive  the  general  provisions  in  this  proposal  so  as 
to  apply  them  to  all  medical  devices.  The  existing 
provisions  of  Directive  90/385/EEC  are  not  affected.  The 
amendments  wi  I I  therefore  not  have  any  effect  on  the 
transposition  of  the  abovementioned  Directive. 
17.  Article  23  - Implementation,  transitional  provisions 
Article  23,  paragraph  4,  provides  for  the  optional 
application  of  the  directive  up  to  June  1997  to  medical 
devices  which  must  undergo  certification  by  a  third  party. 
This  period  is  necessary  in  order  to  avoid  the  additional 
certification  workload  which  would  arise  with  a  shorter 
transitional  period.  To  avoid  the  unnecessary  repetition  of 
tests  and  verifications,  Article  23,  paragraP.h  3,  states 
that  the  notified  bodies  must  take  account  of  the  results  of 
tests  and  verifications  already  carried  out  under  pre-
existing  national  regulations. 
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18.  Annex  1  -Essential  requirements 
This  Annex  is  largely  based  on  Directive  90/385/EEC. 
19.  Annex  8- Procedures  for  devices  for  sbecial  Purposes 
The  procedures  and  statements  referred  to  in  this  Annex 
apply  to  custom-made  devices  and  devices  intended  for 
clinical  investigations.  They  are  based  on  the  solution 
adopted  in  the  Counci I  Directive  relating  to  active 
implantable  medical  devices. 
20.  Annex  9- Classification  rules 
This  Annex  lays  down  the  rules  for  the  classification  of 
medical  devices  for  the  application  of  the  conformity 
assessment  procedures.  The  concept  of  classif1cation  is 
essent i a I I y  based  on  the  vu I nerab iIi ty  of  the  human  body 
following  the  use  of  a  medical  device.  It  also  takes 
account  of  the  consequences  of  functional  defects  in  medical 
devices.  The  basic  criterIa  for  the  classification  rules 
are  as  follows: 
contact  or  interaction  of  a  device  with  the  human  body; 
contact  with  inJured  skin: 
the  invasive  nature  of  a  device  with  regard  to  the 
orifices of  the  human  body  or  of  a  surgtca1  device; 
implantation  of  a  device  in  the  body;  · 
contact  with  vital  organs  (heart,  central  nervous 
system); 
the  del Ivery  of  energy  or  substances  into  or  onto  the 
body. 
On  the  above  basis,  devices  which  do  not  enter  Into  contact 
or  interact  with  the  body  are  generally  classified  in  Class 
I. 
Devices  which  are  invasive  or  implantable  or  which  interact 
with  the  body  are  largely  (apart  from  certain  particular 
aspects)  in  Class  lla  or  lib. 
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A  smal I  number  of  devices  concerning  in  particular  the 
functions  of  vital  organs  are  in  Class  I I I.  Devices  which 
are  activated  by  an  energy  source  and  Which  In  princlple 
should  be  In  Class  I I I  are  already  covered  by  the  Directive 
relating  to  active  implantable  medical  devices.  The 
provisions  of  that  Directive  correspond  to  those  laid  down 
for  Class  I I I  devices. 
21.  Annex  10- Clinical  evaluation 
Annex  10  has  been  adopted  from  the  Directive  relating  to 
active  implantable  Medical  devices.  It  specifi~s  the  subject 
of  the  clinical  data  and  the  procedures  to  be  followed  for 
obtaining  the  data.  Clinical  evaluation  Is  carried  out  under 
the  manufacturer's  responsibility.  It  may  be  a  feature 
reQuired  In  the  technical  documentation  referred  to  in  the 
conformity  assessment  procedures.  The  harmonized  provisions 
con t a I n e d  I n  t h I s  Anne x  w  I I I  a v  o i d  r e p e t I t  ~i on  o f  t he  s am e 
clinical  investigations  in  more  than  one. Member  State. 
22.  Annexes  11  and  12- Minimum  criteria  for  the  notified 
bodies.  EC  marl< 
These  are  Annexes  typical  of  the  new  approach  directives. - 15  -
Proposa I  for  a 
COUNCIL  DIRECTIVE 
concerning medical  devices 
THE  COUNCIL  OF  THE  EUROPEAN  COMMUNITIES 
Having  regard  to  the  Treaty  establishing  the  European  Economic  Community, 
and  In  particular Article 100a  thereof, 
Having  regard  to  the  proposal  from  the  Commission<1>, 
In  cooperation with  the  European  Parliament<2>, 
Having  regard  to  the opinion of  the  Economic  and  Social  Committee<3>, 
Whereas  measures  should  be  adopted  for  the  progressive establ lshment  of  the 
internal  market;  whereas  the  internal  market  Is  an  area  without  internal 
frontiers  in  which  the  free  movement  of  goods,  persons,  services  and 
capital  is ensured; 
Whereas  the  content  and  scope  of  the  laws,  regulations  and  administrative 
provisions  In  force  In  the  Member  States with  regard  to  the  safety,  health 
protect ion  and  performance  characterIstics  of  medIca 1  devices  are 
different;  whereas  the  certification  and  inspection  procedures  for  such 
devices  differ  from  one  Member  State  to  another;  whereas  such  disparities 
constitute barriers to  trade within  the Community; 
Whereas  the  nat iona I  provisions  for  the  safety  and  hea I th  protect ion  of 
patients,  users  and,  where  appropriate,  other  persons,  with  regard  to  the 
use  of  medical  devices  should  be  harmonized  in  order  to guarantee  the  free 
movement  of  such  devices within  the  internal  market; 
(1)  OJ  No  C 
(2)  OJ  No  C 
(3)  OJ  No  C - 16  -
Whereas  the  harmonized  provisions  must  be  distinguished  from  the  measures 
adopted  by  the  Member  States  to  manage  the  fund I  ng  of  pub I I  c  he a I t h  and 
sickness  Insurance  schemes  relating directly or  indirectly  to such  devices; 
whereas,  therefore,  these  provIsIons  do  not  affect  the  ab Ill ty  of  the 
Member  States  to  implement  the  abovementioned  measures  provided  Community 
law  Is  compl led with; 
Whereas  medical  devices  should  provide  patients,  users  and  third  parties 
with  a  high  level  of  protection  and  attain  the  performance  levels 
attributed  to  them  by  the  manufacturer;  whereas,  therefore,  the 
maintenance  or  improvement  of  the  level  of  protection  attained  in  the 
Member  States  Is  one  of  the essential  objectives of  this Directive; 
Whereas 
products 
certain  medical 
within  the 
devices 
meaning 
are 
of 
Intended 
Counc i I 
to  administer  medicinal 
Directive 65/65/EEC  of 
26  January  1965  on  the  approximation  of  provisions  laid  down  by  law, 
regulation  or  administrative 
products<4>,  as  last  amended 
action  relating  to  proprietary  medicinal 
by  Directive 89/381/EEc<5>;  whereas,  in 
such  cases  the  placing  of  the  medicinal  product  on  the  market  is  governed 
by  Directive 65/65/EEC;  whereas  a  d.Jstlnctlon  must  be.  drawn  between  the 
abovementioned  devices  and  medical  devices  incorporating,  inter alia, 
substances  which,  If  used  separate I  y,  may  be  cons I  de red  to  be  a  medici na I 
substance  within  the  meaning  of  Directive 65/65/EEC;  whereas,  in  such 
cases,  If  the  substances  are  incorporated  In  the  medical  devices  to  help 
them  operate,  the  placing of  the  devices  on  the  market  Is  governed  by  this 
Directive;  whereas,  In  this  context,  in  the  event  of  the  bloavai labi l.ity 
of  suchsubstances,  the  safety,  quality  and  usefulness  of  the  substances 
must  be  verified  by  analogy  with  the  appropriate  methods  specified  in 
Counc i I  Directive 75/318/EEC  of  20  May  1975  on  the  approximation  of  the · 
laws  of  the  Member  States  relating  to  analytical,  pharmaco-toxicological 
and  clinical  standards 
proprietary  medicinal 
89/34·1/EEc(7), 
and  protocols  in 
products<6>,  as 
(4)  OJ  No  l  22,  9.2.1965,  p.  369/65. 
(5)  OJ  No  l  181,  28.6.1989,  p.  44. 
(6)  OJ  No  L 147,  9.6.1975,  p.  1. 
(7)  OJ  No  l  142,  25.5.1989,  p.  11. 
respect  of  the  testing  of 
I  ast  amended  by  Direct i.ve - 17  -
Whereas,  In  accordance  with  the  principles  set  out  In  the  Council 
Resolution  of  7  May  1985  concerning  a  new  approach  to  technical 
harmonization  and  standardlzatlon<8>,  rules  regarding  the  design  and 
manufacture  of  medical  devices  must  be  confined  to  the  provisions  required 
to  meet  the  essential  requirements;  whereas,  because  they  are  essential, 
such  requirements  should  replace  the  corresponding  national  provisions; 
whereas  the essential  requirements  should  be  applied with  discrimination  to 
take  account  of  the  technological  level  existing  at  the  time  of  design  and 
of  technical  and  economic  considerations; 
Whereas  Council  Directive 90/385/EEC  of  20  June  1990  on  the  approximation 
of  the  laws  of  the  Member  States  relating  to  active  Implantable  medical 
dev 1  ces<9)  Is  the  first  case  of  app I i cat ion  of  the  new  approach  to  the 
fie I  d  of  medIca I  devices;  whereas  in  the  interest  of  uniform  Community 
rules  applicable  to all  medical  devices,  this Directive  Is  based  largely  on 
the  provisions  of  Directive 90/385/EEC;  whereas,  for  the  same  reasons, 
Directive 90/385/EEC  must  be  amended  to  insert  the  general  provisions  laid 
down  In  this Directive; 
Wher~as the  electromagnetic  compa~~~ility aspects  form  an  integral  part  of 
the  safety  of  medical  devices;  whereas  this  Directive  should  contain 
specific rules on  this subject  with  regard  to  Counci I  Directive 89/336/EEC 
of  3  May  1989  on  the  approximation  of  the  laws  of  the  Member  States 
relating  to  electromagmetic  compatibi 1 ity<10),  as  amended  by  Directive 
91 /263/EEC( 11) 
Whereas  this Directive should  include  requirements  regarding  the  design  and 
manufacture of  devices emitting  ionizing  radiation;  whereas  this Directive 
does  not  affect  the  authorization  required  by  Council 
Directive 80/836/Euratom  of  15  July  1980  amending  the  Directives  laying 
down  the  basic  safety  standards  for  the  health  protection  of  the  general 
public  and  workers  against  the  dangers  of  ionizing  radiatlon<12),  as 
amended  by  Directive 84/467/Euratom<13),  nor  application  of  Council 
Directive 84/446/Euratom of  3  September  1984  laying  down  basic measures  for 
(8)  OJ  No  c 136'  4 . 6 . 1  985 '  p .  1. 
(9)  OJ  No  L  189,  20.7 .1990,  p.  17. 
(10)  OJ  No  L  139,  23.5.1989,  p.  19. 
( 11)  OJ  No  L  128,  23.5.1991,  p.  1. 
(12)  OJ  No  L  246,  17 .9.1980,  p.  1. 
( 13)  OJ  No  L  265,  5.10.1984'  p.  4. 14) 
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the  radiation  protection  of  persons  undergoing  medical  examination  or 
treatment<14);  whereas  Council  Directive 89/391/EEC  of  12  June  1989  on  the 
introduction of  measures  to  encou~age  Improvements  in  the  safet~ and  health 
of  workers  at  worJc(15)  and  the  specHJc. directives  on  the  same  subject 
should  continue  to apply; 
Whereas  this  Directive  does  not  affect  Council  Directive 76/768/EEC  of 
27  July  1976  on  the approximation of  the  laws  of  the  Member  States  relating 
to  cosmetic  products<16),  as  last  amended  by  Directive 91/184/EEc(17); 
whereas  the  assessment  whether  a  product  Is  subject  to  the  abovement toned 
Directive  or  to  this  Directive  must  talce  account,  in  particular,  of  the 
l ntended  purpose  of  the  product  in  quest ion  and  of  the  pI ace  of 
application; 
Whereas,  in  order  to  demonstrate  conformity  with  these  essential 
requirements  and  to  enable  conformity  to  be  verified,  it  is  desirable  to 
have  harmonized  European  standards  to  protect  against  the  risks  associated 
with  the  design,  manufacture  and  packaging  of  medical  devices;  whereas 
such  harmonized  European  standards  are  drawn  up  by  pr.ivate-law  bodies  and 
should  retain  their  status  as  non-mandatory  texts;  whereas~  to  this  end, 
the  European  Committee  for  Standardization  CCEN)  and  the  European  Committee 
' 
for  Electrotechnical  Standardization  (CENELEC)  .are  recognized  as  the 
competent  bodies  for  the  adopt ion  of  harmonized  standards  in  accordance 
with  the general  guide I ines  on  cooperation  between  the  Commission  and  these 
two  bodies  signed on  13  November  1984; 
Whereas,  for  the  purpose  of  this  Directive,  a  harmonized  standard  is  a 
technical  specification  (European  standard  or  harmonization  document) 
adopted,  on  a  mandate  from  the  Commission,  by  either  or  both  of  these 
bodies  in  accordance  with  Counc i I  Directive 83/189/EEC  of  28  March  1983 
laying  down  a  procedure  for  the  provision  of  information  in  the  field  of 
technical  standards  and  regulations<18),  as  last  amended  by  Commission 
Decision  90/230/EEcC19),  and  pursuant  to  the  abovementioned  general 
guidelines;  whereas  with  regard  to  possible  amendment  of  the  harmonized 
standards,  the  Commission  should  be  assisted  by  the  Committee  set  up  under 
(14)  OJ  No  L 265,  5.10.1984'  p.  1. 
(15)  OJ  No  L 183,  29.6.1989,  p.  1 . 
( 16)  OJ  No  L 262,  27 . 9 . 1976 '  p .  169. 
( 17)  OJ  No  L 91,  12.4.1991'  p.  59. 
(18)  OJ  No  L  109,  26.4.1983,  p.  8. 
( 19)  OJ  No  L 128,  1  8 . 5 . 1990 '  p .  15. - 19  -
Directive 83/189/EEC;  whereas  the  measures  to  be  taken  must  be  defined  In 
line  with  procedure  I,  as  laid  down  In  Counci I  Decision  87/373/EEc<20); 
whereas,  for  specific  fields,  what  already  exists  in  the  form  of  European 
Pharmacopoeia  monographs  shou I  d  .be.  incorporated  within  the  framework  . of 
thIs  DIrectIve;  whereas,  therefore,  sever  a I  European  PharmacopoeIa 
monographs  may  be  considered  equal  to  the  abovementioned  harmonized 
standards; 
Whereas,  in  Decision  90/683/EEC  of  13  December  1990  concerning  the  modules 
for  the  various  phases  of  the  conformity  assessment  procedures  which  are 
intended  to  be  used  in  the  technical  harmonization  directives<21),  the 
Counc i I  has  I  aid  down  harmonized  conformity  assessment  procedures; 
whereas  the  application  of  these  modules  to  medical  devices  enables  the 
responsibi I ity  of  manufacturers  and  certification  bodies  to  be  determined 
during  conformity  assessment  procedures on  the  basis of  the  type of  devices 
concerned;  whereas  the  details added  to  these modules  are  justified by  the 
nature of  the verification  required  for  medical  devices; 
Whereas  It  Is  necessary,  essentially  for  the  purpose  of  the  conformity 
assessment  procedures,  to  group  the  devices  into  four  product  c I  asses; 
whereas  the  classification  rules  are  based  on  the  v.ulnerability  of  the 
human  body  taking  account  of  the  potential  risks  associated  with  the 
techn I  ca I  design  and  manufacture  of  the  devices;  whereas  the  conformity 
assessment  procedures  for  Class  I  devices  can  be  carried out,  as  a  general 
rule,  under  the  sole  responsibility of  the manufacturers  in  view  of  the  low 
level  of  vulnerabi I ity  associated  with  these  products;  whereas,  for 
Class  I Ia  devices,  the  intervention of  a  certification body  (notified body) 
should  be  compulsory  at  the  production  stage;  whereas,  for  devices  falling 
within Classes  lib and  I I I  which,  in  case of  malfunction,  constitute a  high 
risk  potential,  inspection  by  a  notified  body  is  required  with  regard  to 
the  design  and  manufacture  of  the  devices;  whereas  Class  1 I I  is  set  aside 
for  the  most  critical  devices  for  which  explicit  prior  authorization  with 
regard  to  conformity  is  required  for  them  to  be  placed on  the  market; 
(20)  OJ  No  L 197,  18.7.1987,  p.  33. 
(21)  OJ  No  L 380,  31.12.1990,  p.  13. - 20  -
Whereas  In  cases.where  the  conformity of  the  devices  can  be  assessed  under 
the  respons I b II I ty  of  the  manufacturer  the  competent  authorItIes  must  be 
able, ·particularly  ln. emergencies,  to  contact  a  person  .responsible  for 
placing  the' device  on  the  market  and ·es.tabl ished  in  the  Community,  whether 
the  manufacturer  or  another  person:  established  in  the  Community  and 
designated  by  the manufacturer  for  the  purpose; 
Whereas  medical  devices  should;  as  a  general  rule,  bear  the  EC  mark  to 
Indicate  their  conformity  with  the. provisions  of  this  Directive  to  enable 
them  to  move  freely  within  the  Community  and  to  be  put  into  service  in 
a.ccordance  with  their  Intended  purpose; 
Whereas,  In  the  fight  against  AIDS  and  in  the  light  of  the  conclusions  of 
the  Council  adopted  on  16 May  1989  regarding  future  activities  on  AIDS 
prevent ion  and  centro I  at  Community  l ev.e 1  (22).  medica 1  devices  used  for 
protection  against  the .HIV  virus  must  afford  a  high  level  of  protection; 
whereas  the  design  and  manufacture of  such  products  should  be  verified  by  a 
notified body; 
Whereas  the  classification  rules  generally  enable  medical·  devices  to  be 
appropriately  classified;  whereas,  in  view  of  the  diverse  nature.of  the 
devices  and  technological  progress  in  this  field,  steps  must  be  taken  to 
include  amongst  the·  implementing  powers  conferred  on  the  Commission  the 
decisions  to  be  taken  with  regard  to  the  proper  classification  or 
reclassification  of  the  devices  or,  where  appropriate,  the  adjustment  of 
the  classification  rules  themselves;  whereas  since  these  issues  are 
closely  connected  with  the  protection  of  health,  it  is  appropriate  that 
these  decisions· should  come  under  procedure  lll(a),  as  provided  for  in 
Decision  87/373/EEC; 
Whereas. It  Is  appropriate  that  the  Member  States,  as  provided  for  by 
Article  100a  of  ·the  Treaty,  may  take  temporary  measures  to  1 imlt  or 
prohibit  the  placing  on  the  market  and  the  use  of  medical  devices  in  cases 
where  they  present  a  particular  risk  to  the  health  of  persons,  provided 
that  the  measures  are  subject  to  a  Community  control  procedure; 
(22)  OJ  No  C  185,  22.7.1989,  p.8. - 21  -
Whereas  the  confirmation  of  compliance  with  the  essential  requirements  may 
mean  that  clinical  Investigations  have  to  be  carried  out  under  the 
responslbl llty  of  the  manufacturer;  whereas,  for  the  purpose  of  carrying 
out  the clinical  Investigations,  appropriate means  have  to  be  specified  for 
the  protection of  public  health  and  publ lc order; 
Whereas  the  appl !cation  of  some  provisions  of  this  Directive  must  be 
facl lltated by  means  of  guidelines published  by  the  Commission; 
Whereas  the  protection  of  health  and  the  associated  controls  may  be  made 
more  effective  by  means  of  a  medical  device  vigilance  system  at  Community 
I  eve I; 
Whereas  this  Directive  covers  the  medical  devices  referred  to  In  Council 
Directive 76/764/EEC  of  27  July  1976  on  the  approximation  of  the  laws  of 
the  Member  States 
thermometers<23),  as 
on  c lin I  ca I  mercury-I  n-g I ass,  max I  mum 
last  amended  by  Directive 84/414/EEc<24); 
reading 
whereas 
the  abovementioned  Directive  must  therefore  be  repealed;  whereas  for  the 
same  reasons  Counci I  Directive 84/539/EEC  of  17  September  1984  on  the 
approximation  of  the  laws  of  the  Member  States  relating  to electro-medical 
equipment  used  in  human  or  veterinary mediclne<25)  must  be  amended, 
HAS  ADOPTED  THIS  DIRECTIVE: 
Article 1 
Definitions.  scope 
1.  This  Directive  shal I  apply  to  medical  devices.  It  also  covers  the 
accessories  to which  the  provisions  for  medical  devices  apply. 
2.  For  the  purposes  of  this Directive,  the  following  definitions  shall 
apply: 
(23)  OJ  No  L 262,  27.9.1976,  p,  139. 
(24)  OJ  No  L 228,  25.8.1984,  p.  25. 
(25)  OJ  No  L 300,  19.11.1984,  p.  179. - 22  -
(a).  "medical  device"  (hereinafter  referred  to  as  "devices")  means  any 
Instrument,  apparatus,  appliance,  material  or  other  article, 
Including  software,. whether  used  alone  or  In  combination,  Intended 
by  the manufacturer  to be  used on  human  beings solely or  principally 
for  the  purpose of: 
diagnosis,  prevention,  monitoring,  treatment  or  alleviation of 
disease,  Injury or  handicap, 
Investigation.  replacement  or  modification  of  the  anatomy  or 
of  a  physiological  process, 
control  of  conception, 
and  which  does  not  achieve  Its  principal  intended  action  in  or  on 
the  human  body  by  pharmacological,  Immunological  or  metabolic means, 
but  which  may  be  assisted  In  Its function  by  such  means. 
(b)  "accessory"  means  an  article which,  while  not  a  device,  Is  required, 
according  . to  the  Intended  purpose  attributed  ~o  it  by  the 
. '· 
manufacturer,  to enable  a  device  to be  used  as  specified. 
(c)  "device  used· for  ln  vltro  diagnosis"  means  any  device  which  is  a 
reagent,  reagent  product,  kit,  Instrument,  equipment  or  system, 
whether  used  alone  or  In  combination,  Intended  by  the  manufacturer 
to  be  used  solely  or  pr lnclpally  In  vltro  for  the  examlnat ion  of 
substances  derived  from  the  human  body  with  a  view  to  providing 
Information  for  the  detection,  diagnosis,  control  or  treatment  of  a 
physiological  state,  of  a  state  of  health  or  disease,  or  of  a 
congenital  abnormality. 
(d)  ··"custom-made  devIce"  means  any  devIce  spec 1  f i call y  made  l n 
accordance  with  a  duly  qual I fled  medical  practitioner's  written 
prescription  which  gives,  under  his  responsibility,  specific  design 
characteristics  and  Is  Intended  to  be  used  only  for  an  Individual 
named  patient. 
The  abovement loned  prescr lpt lon  may  also  be  made  out  by  any  other 
person authorized  by  virtue of  his  professional  qualifications to do 
so. - 23  -
Mass-produced  devices  which  need  to  be  adapted  to meet  the  specific 
requirements  of  the  medical  practitioner  or  any  other  professional 
user  are  not  considered  to be  custom-made  devices. 
(e)  "device  Intended  for  clinical  Investigation"  me.ns  any  device 
intended  for  use  by  a  duly  qualified  medical  practitioner  when 
conducting  investigations as  referred  to  in  point  2.1 of  Annex  10  in 
an  adequate  human  cl lnlcal  environment. 
For  the  purpose  of  conducting  clinical  investigation,  any  other 
person  who,  by  virtue  of  his  professional  qualifications,  is 
authorized  to  carry  out  such  investigation  shall  be  accepted  as 
equivalent  to a  duly  qualified medical  specialist. 
(f)  "Implantable  device"  means  any  device which  Is  Intended: 
to be  totally or  partially  Introduced  lrito  the. human  body  or  a 
natural  orifice or 
to  replace  an  epithelial  surface or  the  surface of  the  eye 
by  surgical  intervention,  which  Is  Intended  to  remain  after  the 
procedure  for  at  I  east  30  days,  and  whIch  can  on I  y  be  removed  by 
medical  or  surgical  Intervention. 
(g)  "manufacturer"  means  the  natural  or  legal  person  with  overall 
responsibility  for  the  design,  manufacture,  packaging  and  label I ing 
of  a  device  before  It  Is  pI aced  on  the  market  on  'hIs  own  beha 1  f, 
regardless  of  whether  these  operations  are  carried  out  by  that 
person  himself  or  on  his behalf  by  a  third party. 
The  natural  or  legal  person  who  assembles,  packages,  processes 
and/or  labels one  or  more  ready-made  products  and/or  assigns  to  them 
their  Intended  purpose  as  a  device with  a  view  to their  being  placed 
on  the  market  on  his  own  behalf  is  also  considered  to. be.  a 
manufacturer.  This  sub-paragraph  does  not  apply  to  the  person  who, 
while  not  a  manufacturer  within  the  meaning  of  the  first 
sub-paragraph,  assembles  or  adapts  devices  already  on  the  market  to 
their  Intended  purpose  for  an  Individual  patient. - 24  -
(h)  "Intended  purpose"  means  the  use  for  which  the·devlce. is  intended 
and  for  which  It  Is  suited  according. to  the  data  suppl led  by  the 
manufacturer  on  the  label ling,  In  the  Instructions  and/or  in 
promotional  materials. 
(i)  "placing  on  the  market"  means  the  first  making  available  in  return 
for· payment  or  free  of.  charge  of  a.  device  other  than  a  device 
intended  for  clinical  investigation,  with  a  view  to  distribution 
and/or  use  on  the  Community  market,  regardless of  whether  it  is  new 
or  fully  refurbished. 
(J)  "putting  Into-service"  means  the  stage  when  a  device  is  ready  for 
use  for  the  first  time  on  the  Community  market  for  its  Intended 
purpose. 
(k)  "bloavallabi llty"  means  the  release  of  a  substance  into or  onto  the 
human  body  in  such  a  way  that  the  interact ion  with  the  body  can 
reasonably  be  detected. 
3.  Where  a  device  Is  Intended  to  administer  a  subst~ance  defined  as  a 
medicinal  product  within  the  meaning  Article  1  of 
Di.rectlve  65/65/EEC,  that  substance  shall  be  subject  to  the 
marketing  authorization system  provided  for  in  that  Directive. 
4.  Where  a  device  Incorporates,  as  an  integral  part,  a  substance which, 
If  used  separately,  may  be  considered  to  be  a  medicinal  product 
within  the  meaning  of  Article  1  of  Directive 65/65/EEC,  that  device 
must  be  assessed  and  authorized  In  accordance  with  this  Directive. 
5.  This  Directive does. not  apply  to: 
(a)  devices  used  for  in vttro diagnosis, 
(b)  active  implantable devices covered  by  Directive 90/385/EEC. 
6.  This  Directive  Is  a  specific  directive  within  the  meaning  of 
Article  2(2)  of  Directive 89/336/EEC. - 25  -
7.  This  Directive  does  not  affect  the  appl lcatlon  of 
Directive 80/836/Euratom,  nor  of  Directive 84/466/Euratom. 
8.  This  Directive  does  not  affect  the  appl !cation  of 
Directive 76/768/EEC.  The  assessment  whether  a  product  is  subject 
to  the  abovementioned  DirectIve  or  to  thIs  DIrectIve  sha I I  tal<e 
account,  in  particular,  of  the  Intended  purpose  of  the  product  in 
Question  and  of  the  place of  appl icatlon. 
Article  2 
Placing on  the market  and  putting  Into service 
Member  States  shal I  take  all  necessary  steps  to  ensure  that  devices  may  be 
placed  on  the  market  and  put  into  service  only  if  they  do  not  compromise 
the  safety  and  health  of  patients,  users  and,  where  applicable,  other 
persons  when  properly  installed,  maintained  and  used  in  accordance  with 
their  intended  purpose. 
Article  3 
Essential  requirements 
The  devices  must  meet  the  essential  reQuirements  set  out  in  Annex  t  which 
app I  y  to  them,  tal< I  ng  account  of  the  Intended  purpose  of  the  devices 
concerned. 
Article  4 
Free  movement.  devices  Intended  for  special  purposes 
1.  Member  States  shal I  not  create  any  obstacles  to  the  placing  on  the 
market  or  the  putting  Into  service within  their  territory of  devices 
bearing  the  EC  mark. 
2.  Member  States shall  not  create any  obstacle~ to: 
devices  intended  for  clinical  invest I  gat ion  being  made 
avai-lable  to  medical  specialists  or  authorized  persons  for 
that  purpose  if  they  meet  the  conditions  laid  down  in 
Article  15  and  In  Annex  8. ISJ 
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custom~ade devices  being  placed  on  the  market  and  put  into 
service  If  they meet  the conditions  laid down  in  Article  11  In 
combination with Annex  8; Class  Ita,  lib and  I II  devices  shal 1 
be  accompanied  by  the  statement  referred  to  In  Annex  8. 
These  devices shalt  not  bear  the  EC  mark. 
3.  At  trade  fairs,  exhibitions,  demonstrations,  etc.  Member  States 
shall  not  create  any  obstacles  to  the  showing  of  devices  which  do 
not  conform  to  this Directive,  provided  that  a  visible  sign  clearly 
Indicates  that  such  devices  cannot  be  marketed  or  put  Into  service 
until  they  have  been  made  to comply. 
4.  Member  States may  require  the  information  referred  to  In  points  13.3 
and  13.6  of  Anne~  1  to  be  In  their  national  language(s)  when  a 
device  reaches  the  final  user,  regardless  of  whether  it  is  for 
professional  or  other  use. 
Article 5 
Reference  to  standards 
1.  Member  States  shall  presume  compl lance  with  the  essential 
reQui.rements  referred  to  in  Article 3  in  respect  of  devices  which 
are  in  conformity  with  the  relevant  provisions  of  the  harmonized 
•tanda~ds,  the  references  of  which  have  been  published  in  the 
Official  Journal  of  the  European  Communities.  Member  States  shal I 
publish  the  references of  the  national  standards which  transpose  the 
abovementioned  harmonized  standards  into  national  law. 
2.  For  the  purposes  of  this  Directive,  reference  to  harmonized 
standards also  Includes  the monographs  of  the  European  Pharmacopoeia 
on  surgical  sutures  and  on  interaction  between  medicinal  products 
and  materials  used  as  containers  for  devices,  the  references  of 
whIch  have  been  pub I i shed  In  the  Off I  cIa I  Jour na I  of  the  European 
Communities. - 27  -
3.  Where  the  Commission,  whether  on  Its  own  initiative  or  at  the 
request  of  one  of  the  Member  States,  considers  that  the  harmonized 
standards  do  not  entirely  meet  the  essential  requirements  referred 
to  In  Article 3,  the  measures  to  be  taken  by  the  Member  States with 
regard  to  thes~  standards  and  the  publication  referred  to  In 
paragraph  1  of  this  Article  shal I  be  adopted  by  the  procedure 
defined  in  Article 6(2). 
Article 6 
Committee  on  Standards  and  Technical  RegulatiOns 
1.  The  Commission  shall  be  assisted  by  the  committee  set  up  by 
Article 5  of  Directive 83/189/EEC. 
2.  The  representative of  the Commission  shal I  submit  to  the  committee  a 
draft  of  the  measures  to  be  taken.  The  committee  shal I  deliver  its 
opinion on  the draft,  within  a  time  limit  which  the  chairman  may  lay 
down  according  to  the  urgency  of  the matter,  if  necessary  by  taking 
a  vote. 
The  opinion  shall  be  recorded  in  the  minutes;  In  addition,  each 
Member  State  sha II  have  the  right  to  ask  to  have  Its  posit ion 
recorded  in  the minutes. 
The  Commission  shall  take 
de I i vered  by  the  commit tee. 
the  utmost  account  of  the  opinion 
It  shall  Inform  the  committee  of  the 
manner  In  which  its opinion has  been  taken  Into  account. 
Article 7 
Committee  on  Medical  Devices 
1.  The  Commission  shal I  be  assisted  by  the  committee  set  up  by 
Article 6(2)  of  Directive 90/385/EEC. - 28  -
2.  The  representative of  the  Commission  shall  submit  to  the  committee  a 
draft  of  the  measures  to  b~. taken.  The  convn I ttee  sha II  de II ver  1 ts 
opinion on  the  draft  within  a  time  limit  which  the  chairman  may  lay 
down  acc.ordlng  to  the  urgency  of  the  matter.  The  opinion .shall  be 
delivered  by  the  majority  laid  down  In  Article 148(2)  of  the  Treaty 
In  the case of  decisions which  the Council  Is  required  to adopt  on~ 
proposal  from  the  Commission.  The  votes  of  the  representatives  of 
the  Member  States  within  the  committee  shall  be  weighted  In  the 
manner  set out  In  that Article.  The  chairman  shall  not  vote. 
The  Commission  shall  adopt  the  measures  envisaged  If  they  are  In 
accordance with  the opinion of  the  committee. 
If  the  measures  envisaged  are  not  In  accordance  with  the  opinion of 
the  committee,  or  If  no  opinion  Is  delivered,  the  Commission  shall, 
without  delay,  submit  to  the  Council  a  proposal 
measures  to  be  taken.  The  Council  shall  act 
majority. 
rel~ting  to  the 
by  a  qual I fled 
If,  on  the  expIry  of  a  per lod  of  three  months  from  the  date  of 
referra I  to  the  Counc II.  the  Counc I I  has  not  acted.  the  proposed 
measures  shal I  be  adopted  by  the Commission. 
3.  The  committee  may  examine  any  question  connected  with  implementlon 
of  this Directive. 
Article 8 
Safeguard  clause 
1.  Where  a  Member  State  ascertaIns  that  the  devIces.  when  correct I  y 
Instal led,  maintained  and  used  for  their  Intended  purpose,  may 
compromise  the  health  and/or  safety  of  patients,  users  or,  where 
applicable,  other  persons,  it  shall  take  all  appropriate  interim 
measures  to  withdraw  such  devices  from  the  market  or  prohibit  or 
restrict  their  being  placed on  the market  or  put  into service. 
The  Member  State shal I  immediately  inform  the  Commission  of  any  such 
measures,  indicating  the  reasons  for  its  decision  and,  in 
particular,  whether  non-compliance  with  this Directive  is  due  to: - 29  -
(a)  failure  to  meet  the  essential  requirements  referred  to  in 
Article  3; 
(b)  Incorrect  applIcation  of  the  standards  referred  to  in 
Article 5,  In  so  far  It  Is  claimed  that  the  standards  have 
been  app I I ed; 
(c)  shortcomings  In  the  standards  themselves. 
These  measures  are  appl lcable  until  the  entry  Into  force  of  the  act 
provided  for  in  paragraph  2. 
2.  The  measures  adopted  under  paragraph  1  shal I  be  confirmed  and 
extended,  possibly  amended,  to  the whole  Community  or  repealed  by  an 
act  of  the Commission. 
However.  where  the  measures  were  adopted  under  paragraph  1  on  the 
ground  of  a  shortcoming  in  the  standards  provided  for  in  Article 5, 
the  procedure  laid  down  in  Article 6(2)  is applicable. 
3.  Where  a  non-complying  device  bears  the  EC  mark,  the  competent 
Member  State  shall  take  appropr late  act ion  against  whomsoever  has 
affixed  the  mark  and  shall  inform  the  Commission  and  the  other 
Member  States  thereof. 
4.  The  Commission  shal I  ensure  that  the  Member  States are kept  Informed 
of  the  progress  and  outcome  of  this procedure. 
1 .  Devices  sha I I 
Classification 
Article 9 
Classification 
be  divided  into  Classes  I, 
shall  be  carried  out  In 
classification rules set out  in  Annex  9. 
lla,  lib 
accordance 
and 
with 
Ill. 
the - 30  -
2.  Where  there  Is  doubt  over  the  classification  resulting  from 
application  of  the  rules  contained  In  Annex  9,  the  manufacturer  or 
his  authorized  representative  established  In  the  Community  may  ask 
the  competent  authorities  to  take  a  decision.  In  the  event  of  a 
dispute  between  the  manufacturer  and  the  notified  body  concerned 
defined  In  Article  16  resulting  from  the  application  of  the 
abovementioned  rules,  the  latter  shall  refer  the  matter  to  the 
competent  authorities who  wl  II  reach  a  decision. 
3.  The  classification  rules  set  out  in  Annex  9  may  be  adapted  In 
accordance  wIth  the  procedure  referred  to  In  Art i c I  e  7(2)  In  the 
I lght  of  technical  progress  and  any  Information  which.  becomes 
available under  the  Information  system  provided  for  in  Article  10. 
Article  10 
Information on  incidents occurring  following  placing 
of  devices on  the market 
1.  Uember  States  sha II  take  the  necessary  steps  to  ensure  that  any 
Information  brought  to  their  knowledge,  in  accordance  with  the 
provisions  of  this  Directive,  regarding  the  Incidents  mentioned 
below  involving  a  Class  lla,  lib  or  Ill  device  is  recorded  and 
evaluated  in  a  central lzed  manner: 
(a)  any  deterioration  In  the characteristics and/or  performance  of 
a  device~  as  wei  I  as  any  inaccuracies  in  the  Iabeii ing  or  the 
instruction  leaflet  which  might  lead  to  or  might  have  led  to 
the  death  of  a  patient  or  user  or  to  a  serious  deterioration 
in  his state of  health; 
(b)  any  technical  or  medical  reason  connected  with  the  device 
leading  to  systematic  recall  of  devices  of  the  same  type  by 
the manufacturer. - 31  -
2.  Where  a  Member  State  obliges  medical  practitioners  or  the  medical 
Institutions  to  Inform  the  competent  authorities  of  any  Incidents 
referred  to  In  paragraph  1.  It  sha II  take  the  necessary  steps  to 
ensure  that  the  manufacturer  of  the  device  concerned,  or  his 
authorized  representative  establ lshed  In  the  Community,  Is  also 
Informed of  the  Incident. 
3.  After  carrying  out  an  assessment,  If  possible  together  with  the 
manufacturer,  Member  States  shall,  without  prejudice  to  Article 8, 
Immediately  inform  the  Commission  and  the  other  Member  States of  the 
incidents  referred  to  in  paragraph  1  for  which  relevant  measures 
have  been  taken or  are  contemplated. 
4.  The  Commission  shall  adopt  the  necessary  measures  concerning  the 
functioning of  the  Information  system  referred  to  in  paragraphs  1,  2 
and  3  and  the  presentation of  information. 
Article  11 
Conformity  assessment  Procedures 
1.  In  the  case  of  devices  falling within  Class  I I I,  other  than  devices 
which  are  custom-made  or  intended  for  clinical  Investigations,  the 
manufacturer  shall,  in order  to affix  the  EC  mark,  either: 
(a)  follow  the  procedure  relating  to  the  EC  declaration  of 
conformity set  out  in  Annex  2  (ful I  Qual lty guarantee),  or 
(b)  follow  the  procedure  relating  to  EC  type-examination  set  out 
In  Annex  3,  coupled  with: 
(I)  the  procedure  relating  to  EC  verification  set  out  In 
Annex  4,  or 
(II)  the  procedure  relating 
conformIty  set  out  In 
guarantee). 
to  the  EC  declaration  of 
Annex  5  (product ton  QUa I I ty - 32  -
2.  In  the  case  of  devices  falling  within  Class  I Ia,  other  than  devices 
which  are  custom-made  or  Intended  for  clinical  Investigations,  the 
manufa~turer  shall,  In  order  to  affix  the  EC  mark,  follow  the 
proced4-.r,.e.  relating  to  the  EC  declaration  of  conformity  set  out  In 
Annex  7,  coupled with either: 
(a)  the  procedure  relating  to  EC  verification set  out  in  Annex  4, 
or 
(b)  the procedure  relating  to  the  EC  declaration of  conformity  set 
~ut  In  Annex  5  (production qual lty guarantee),  or 
(c)  the  procedure  relating  to  the  EC  declaration of  conformity  set 
out  In  Annex  6  (product  quality guarantee). 
Instead  of  applying  these  procedures,  the  manufacturer  may  also 
follow  the  procedure  referred  to  in  paragraph  3(a). 
3.  In  the  case  of  devices  falling within  Class  I lb,  other  than  devices 
which  are  custom-made  or  Intended  for  cl inlcal  investigations,  the 
manufacturer  shal I,  In  order  to affix  the  EC  mark,  either: 
(a).  follow  the  procedure  relating  to  the  EC  declaration  of 
conformity  set  out  In  Annex  2  (full  quality  guarantee);  in 
this case,  point  4 of  Annex  2  Is  not  applicable;  or 
(b)  follow  the  procedure  relating  .to  EC  type-examination  set  out 
In  Annex  3,  coupled with: 
(I)  the  procedure  relating  to  EC  verification  set  out  In 
Annex  4,  or 
(II). the  procedure  relating 
conformity  set  out  In 
guarantee),  or 
to  the  EC  declaration  of 
Annex  5  (production  quality 
( I i I)  the  procedure  relating  to  the  EC  declaration  of 
conformity  set  out  In  Annex  6  (product  quality 
guarantee). - 33  -
4.  In  the  case  of  devices  falling  within  Class  I,  other  than  devices 
which  are  custom-made  or  Intended  for  clinical  investigations,  the 
manufacturer  shal I  follow  the  procedure  referred  to  In  Annex  7  and 
draw  up  the  EC  declaration of  conformity  required  before placing  the 
device  on  the market. 
5.  In  the  case  of  custom-made  devices,  the  manufacturer  shall  follow 
the  procedure  referred  to  In  Annex  8  and  draw  up  the  statement  set 
out  in  that  Annex  before  placing each  device on  the market. 
6.  During  the  conformity  assessment  procedure  for  a  device,  the 
manufacturer  and/or  the  not If led  body  sha II  take  account  of  the 
results  of  any  assessment  and  verification operations  which,  where 
appropriate,  have  been  carried out  In  accordance  with  this Directive 
at  an  intermediate stage of manufacture. 
7.  The  manufacturer  may  instruct  his  authorized  representative 
established  in  the  Community  to  initiate the  procedures  provided  for 
in  Annexes  3,  4,  7  and  8. 
8.  Where  the  conformity  assessment  procedure  involves  the  intervention 
of  a  notified  body,  the  manufacturer,  or  his  authorized 
representative  established  in  the  Community,  may  apply  to  a  body  of 
his  choice  within  the  framework  of  the  tasks  for  which  the  body  has 
been  notified. 
9.  Decisions  taken  by  the  notified  bodies  in  accordance·with  Annexes  2 
and  3  shal I  be  valid  for  a  maximum  of  five  years  and  may  be  extended 
on  application  for  further  periods of  five  years. 
10.  The  records  and  correspondence  relating  to  the  procedures  referred 
to  in  paragraphs  1  to  5  sha II  be  in  an  offici a I  I  anguage  of  the 
Member  State  in  which  the  procedures  are  carrie~  out  or  in  a 
language  acceptab~e to  the  notified body. (6) 
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Article  12 
Assembly  and  sterilization 
1.  Any  natural  or  legal  person  who  assembles  devices  bearing  the  EC 
mark  for  their  Intended  purpose  and  within  the  I imits  of  use 
specified  by  their  manufacturers  with  regard  to  their  compatibility 
with other  devices  In  order  to  put  them  on  the market  in  the  form  of 
a  system,  kit or  operation pack  shal I  draw  up  a  declaration  in  which 
he  states that: 
(a)  he  has  verified  the  mutual  compatibility of  the  devices  which 
make  up  the  system,  kit  or  operation  pack  In  accordance  with 
the  manufacturers'  instruct Ions  and  that  assembly  has  been 
carried out  In  accordance  with  these  instructions; 
(b)  the  system,  kit  or  operation  pack  has,  where  applicable,  been 
packaged  In  accordance  with  the manufacturers'  instructions or 
the  limits  appl !cable to  the  various  devices; 
(c)  all  of  the activities referred  to  In  (a)  and  (b)  are.subjected 
to appropriate methods  of  control  and  inspection. 
Any  such  system,  kit or  operation  pack  shall  not  bear  any  additional 
EC  mark.  It  shal I  be  accompanied  by  the  Information  referred  to  in 
point  13  of  Annex  1  which  Includes,  where  appropriate,  the 
Information  supplied  by  the  manufacturers  of  the  devices  which  have 
been  assembled. 
2.  Any  natural  or  legal  person  who,  in  the  framework  of  an  activity 
referred  to  paragraph  1,  sterilizes  devices  bearing  the  EC  mark, 
shall,  at  his  choice,  follow  one  of  the  procedures  referred  to  in 
Annex  4  or  5.  The  application of  the  abovementioned  Annexes  and  the 
Intervention  of  the  notified  body  are  limited  to  the  aspects  of  the 
procedure  relating  to  the  obtaining  of  steri 1 ity.  The  person  shall 
draw  up  a  declaration  stating  that  sterilization·has  been  carried 
out  In  accordance with  the manufacturer's  instructions. - 35  -
3.  This Article does  not  apply  If one  of  the devices  concerned  does  not 
bear  the  EC  mark  or  If  the  EC  m~rk  for  one  of  the  devices  has  been 
affixed  for  a  different  Intended  purpose. 
Article  13 
Decisions with  regard  to classification.  derogation clause 
1.  Where  a  Member  State considers  that 
(a)  application  of  the  classification  rules  set  out  In  Annex  9 
requires  a  decision  with  regard  to  the  classification  of  a 
given  device or  family  of  devices,  or 
(b)  a  given  device  or  family  of  devices  should  be  classified,  by 
way  of  derogation  from  the  provisions  of  Annex  9,  In  another 
class,  or 
(C)  the  conformity  of  a  device  or  family  of  devices  should  be 
establ lshed,  by  way  of  derogation  from· the  provisions  of 
Article  11,  by  applying  solely  one  of  the  g1iven  procedures 
chosen  from  among  those  referred  to  In  Article 11, 
it  shal I  submit  a  duly  substantiated  request  to  the  Commission  and 
ask  It  to  take  the  necessary  measures.  Where  approprIate,  these 
measures  shall  be  adopted  In  accordance  with  the  procedure  referred 
to  In  Article 7(2). 
2.  The  Commission  sha II  Inform  the  Member  States of  the  measures  taken 
and,  where  appropriate,  publish  the  relevant  parts of  these measures 
in  the Official  Journal  of  the  European  Communities. - 36  -
Article  14 
Registration of  Persons  resPonsible  for  Placing devices on  the market 
1 .  Any  manufacturer  who.  on  hIs  own  beha If.  pI aces  devIces  on  the 
market  In  accordance  with  the  procedures  referred  to  In 
Article 11(4)  and  (5)  shall  Inform  the  competent  authorities of  the 
Member  State  In  which  he  has  his  registered place of  business of  the 
address  of  the  registered  place  of  business  and  the  category  of 
devices  concerned. 
2.  Where  a  manufacturer  who  places  devices  referred  to  in  paragraph  1 
on  the  market  on  his own  behalf  does  not  have  a  registered  place of 
business  In  a  Member  State.  he  shall  designate  the  person(s) 
respons i b I  e  for  marketIng  them  and  estab l i  shed  In  the  CommunIty. 
These  persons  sha I I  Inform  the  competent  authorItIes  of  the 
Member  State  in  which  they  have  their  registered  place  of  business 
of  the  addr~ss of  the  registered  place  of  business  and  the  category 
of devices  concerned. 
3.  The  Member  States ,shall  on  request  inform  the  other  t.4ember  States 
and  the Commission  of  the detai Is  referred  to  in  paragraphs  1  and  2. 
Article  15 
Clinical  investigation 
1.  In  the  case  of  devices  falling  within  Classes  I,  Ita  and  lib  which 
are  Intended  for  clinical  Investigations,  the  manufacturer,  or  his 
authorized  representative established  in  the Community,  shall  follow 
the  procedure  referred  to  in  Annex  8  and  keep  the  statement 
concerned at  the disposal  of  the  competent  authorities. 
2.  In  the  case  of  devices  falling  within  Class  Ill  and  Implantable 
devices  fat I ing  within  Classes  I Ia  or  lib  intended  for  cl inlcal 
Investigations,  the  manufacturer,  or  his  authorized  representative 
established  In  the Community,  shall  follow  the  procedure  referred  to 
In  Annex  8  and,  at  I  east  45  days  before  the  commencement  of  the 
Investigations,  submit  the  statement  referred  to  In  the 
abovementioned  Annex  to  the  competent  authorities  of  the 
Member  State  In  which  the  Investigations are  to be  conducted. - 37  -
The  manufacturer  may  convnence  the  relevant  clinical  Investigations 
at  the  end  of  a  period  of  45  days  after  notification,  unless  the 
competent  authorities  have  notified  him  within  that  period  of  a 
decision  to  the  contrary based on  considerations of  pub! lc  health or 
pub I I  c  order. 
3.  The  clinical  Investigations must  be  conducted  In  conformity  with  the 
provisions  of  Annex  10.  The  provisions  of  Annex  10  shall  be 
adjusted  In  accordance with  the  procedure  laid  down  l~n  Article 7(2). 
4.  The  Uember  States shall,  If  necessary,  take  the appropriate steps  to 
ensure  pub! lc  health  and  pub! lc  order. 
5.  The  manufacturer  or  his  authorized  representative establ1shed  In  the 
Community  shal I  keep  the  report  referred  to  In  point  2.3.7  of 
Annex  10  at  the  disposal  of  the  competent  authorities. 
6.  The  provisions of  paragraphs  1  and  2  do  not  apply where  the  cl lnlcar 
Investigations  are  conducted  using  devices  which  are  authorized  In 
accordance  with  Article  11  to  bear  the  EC  mark  unless  the  aim  of 
these  Investigations  Is  to  use  the  devices  for  a  purpose  other  than 
that  referred  to  In  the  relevant  conformIty  assessment  procedure. 
The  relevant  provislons of Annex  10  remain  applicable. 
Article  16 
Notified bodies 
1.  The  Uember  States  shal I  notify  the  other  Uember  States  and  the 
Commission  of  the  bodies which  they  have  designated  for  carrying out 
the  tasks  pertaining  to  the  procedures  referred  to  in  Articles  11 
and  18  and  the  specific  tasks  for  which  the  bodies  have  been 
designated.  in  this  Directive,  these  bodies  are  referred  to  as 
"notified bodies". 
The  Comml ss ion  sha II  a I locate  an  identification  number  to  these 
bodies  and  inform  them  and  the  Member  States  of  it.  It  shal I 
publish  a  list  of  the  notified  bodies,  together  with  the 
I  dent If I  cat ion  numbers  It  .has  a r located  to  them  and  the  tasks  for 
which  they  have  been  notified,  In  the  Official  Journal  of  the 
European  Communities.  It  shal I  ensure  that  the  I 1st  Is  kept  up  to 
date. - 38  -
2.  Member  States  shall  apply  the  minimum  criteria  set  out  In  Annex  11 
for  the  designation  of  bodies.  Bodies  that  meet  the  criteria  laid 
down  In  the  relevant  harmonized  standards  shal-l  be  presumed  to meet 
the  relevant  minimum  criteria. 
3~  A  Member  State  that  has  notified  a  body  shal I  withdraw  that 
notification  If  It  finds  that  the  body  no  longer  meets  the  criteria 
referred  to  in  paragraph -2.  It  shall  Immediately  Inform  the  other 
Member  States and  the Commission  thereof. 
4.  The  notified  body  and  the  manufacturer,  or  his  authorized 
representative  established  In  the  Community,  shall  lay  down,  by 
common  accord,  the  time  I lmlts  for  completion  of  the  assessment  and 
verification operations referred  to  in  Annexes  2  to 6. 
Art lcle  17 
EC  marking 
1.  DevIces,  other  than  devIces  whIch  are  custom-made  or  Intended  for 
cl lnlcal  Investigations,  considered  to  meet  the  essential 
requirements  referred  to  in  Article  3  must  bear  the  EC  mark  of 
conformity when  they  are  placed on  the market. 
2.  The  EC  mark  of  conformity,  as  shown  In  Annex  12,  must  appear  In  a 
visible,  legib·le  and  lndel lble  form  on  the device,  where  practicable 
and  appropriate,  and/or  on  the  sales  packaging  and  the  instruction 
leaflet. 
It  shal I  be  accompanied  by  the  identification number  of  the notified 
body  responsible  for  implementation  of  the  procedures  set  out  In 
Annexes  2,  4,  5  and  6  and  the  last  two  digits of  the  year  In  Which 
the mark  was  affixed. 
I 
3.  In  the  event  of  a  significant  change  in  the  intended  purpose  of  a 
device.  the  EC  mark  may  be  affixed  only  if  the  manufacturer  or, 
where  appropriate,  his  authorized  representative  established  In  the 
Community,  has  followed  the applicable procedures  In  accordance with 
Art I  c I  e  1-1  • - 39  -
4.  It  Is  prohibited  to  affix  marks  which  may  be  confused  with  the  EC 
mark  of  conformity. 
Article 18 
Obligations of  the notified body  In  the  case of  a  wrongly  affixed mark 
Where  It''  Is  found  that  the  EC  mark  has  been  wrongly  affixed,  the  notified 
body  which  carried out  the  assessment  of  conformity  shall  take  appropriate 
measures  and  forthwith  Inform  the  competent  Uember  State  thereof.  The 
competent  Uember  State  shal I  Inform  the  other  Uember  States  and  the 
Commission  thereof. 
Article  19 
Decisions  In  respect  of  refusal  or  restriction 
1.  Any  decision  taken  pursuant  to  this Directive: 
(a)  to  refuse or  restrict  the  placing on  the market  or  the putting 
Into  service  of  a  device  or  the  carrying  out  of  clinical 
Investigations.  or 
(b)  to withdraw  devices  from  the market, 
shall  state  the  exact  grounds  on  which  It  Is  based.  Such  decisions 
shall  be  notified without  delay  to  the party concerned,  who  shall  at 
the same  time  be  Informed  of  the  re~edles available  to  him  under  the 
national  law  In  force  In  the  Uember  State  In  question  and  of  the 
time  I lmlts  to which  such  remedies  are subject. 
2.  In  the  event  of  a  decision  to withdraw  devices  from  the  market,  the 
manufacturer.  or  his  authorized  representative  established  In  the 
Community,  shall  have  an  opportunity  to put  forward  his viewpoint  In 
advance,  unless  such  consultation  Is  not  possible  because  of  the 
urgency  of  the measure  to be  taken. - 40  -
Article  20 
Confidentiality 
Without  prejudice  to  the  existing  national  provisions  and  practices  on 
medical  secrets,  Uember  States  shall  ensure  that  all  the  parties  Involved 
in  the  application  of  this  Directive  are  bound  to  observe  confidentiality 
with  regard  to  all  Information  obtained  In  carrying out  their  tasks.  Thl.s 
does  not  affect  the  obligations  of  Uember  States  and  notified  bodies  with 
regard  to  mutual  information  and  the  dissemination  of  warnings,  nor  the 
obligations of  the  persons  concerned  to  provide  Information  under  criminal 
law. 
Article  21 
Guidelines 
The  Commission  shal I  adopt  the  necessary  guidelines  for  the  uniform 
appl icatlon of  this Directive  In  respect  In  particular of: 
• '  ~ . •  :'11 
(a)  the  scope of  the  Directive, 
(b)  the classification of  devices, 
(c)  the conformity  assessment  procedures. 
The  Commission  shall  publish  these  guidelines  in  the  Official  Journal  of 
the  European  Communities. 
Article  22 
Repeal  and  amendment  of  Directives 
1.  Directive  76/764/EEC  is  hereby  repealed  with  effect  from 
1  July  1994. 
2.  In  the  title  and  Article 1  of  Directive  8:4/539/EEC,  the  words 
"human  or"  are del.eted. 3. 
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The  following  paragraph  6  Is  added  to  Article  1  of 
Directive 90/385/EEC: 
"6.  The  following  provts·tons  of  Counci I  Directive 
..  / •..  /EEc(26)  [on  medical  devices]  also  apply  to 
active  Implantable  medical  devices:  Article 1(2)(g) 
and  (I);  Article 11(6),  (8)  and  (9);  Article 13(1)(c) 
coupled  with  Article 7;  Article  17(3);  Article 19(2); 
Artlc1e  21  points  (a)  and  (c)  of  the first paragraph." 
Article  23 
Implementation.  transitional  provisions 
1.  Member  States  sha I I  adopt  and  pub I ish  the  I aws.  regu I at ions  and 
administrative  provisions  necessary  to  comply  with  this  Directive 
not  later  than  31  December  1993.  They  shall  immediately  inform  the 
Commission  thereof. 
The  standing  committee  referred  to  in  Article 7  may  assume  its 
tasks  from  the  date  of  notification of  this  Directive.  The  Member 
States  may  take  the  measures  referred  to  In  Article  16  within  six 
months  of notification of  this Directive. 
When  Member  States  adopt  these  provisions,  these  sha I I  contaIn  a 
reference  to  this  Directive  or  sha I I  be  accompanied  by  such  a 
reference  at  the  time  of  their  official  publication.  The 
procedure  for  such  reference  shall  be  adopted  by  Member  States. 
Member  States  sha II  app I y  these  provIsIons  with  effect  from 
1  July  1994. 
2.  Member  States  shal I  communicate  to  the  Commission  the  texts  of  the 
provisions of  national  law  which  they  adopt  In  the  field  covered  by 
this Directive. 
(26) 17) 
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3.  Member  States  sha II  take  the  necessary  act ion  to  ensure  that  the 
notified  bodies  which  are  responsible  pursuant  to  Article  11(1)  to 
(4)  for  the  assessment  of  the  conformity  of  devices  already  placed 
on  the  market  prior  to  the  Implementation  of  this  Directive  take 
account  of  the  results  of  tests  and  verifications  already  carried 
out  under  pre-existing  national  law  In  respect  of  such  devices  and 
of  any  other  relevant  Information  regarding  the  characteristics  and 
performance  of  such  devices. 
4.  In  the  case  of  devices  whIch,  for  the  purposes  of  thIs  DirectIve, 
must  be  the  subject  of  one  of  the  procedures  referred  to  in  Annexes 
2  to  6,  Member  States  shall  accept  the  placing  on  the  market  and 
putting  into service of  devices  which  conform  to  the  rules  in  force 
In  their  territory  on  30  June  1994  during  the  period  up  to 
30  June  1997.  In  the  case  of  other  devIces  I  awfu I I  y  pI aced  on  the 
market  before  30  June  1994,  Member  States  shall  accept  their  being 
put  Into service during  the  period up  to  30  June  1995. 
In  the  case  of  devices  which  have  been  subjected  to  EEC  pattern 
approval  in  accordance  with  Directive  76/764/EEC,  Member  States 
shall  accept  their  being  placed  on·the  market  and  put  Into  service 
during  the  period up  to  30  June  2004. 
Article  24 
This Directive  is  addressed  to  the  Member  States. 
Done  at  Brussels,  For  the Counc I I 
The  President - 43  -
ANNEX  1 
ESSENTIAL  REQUIREMENTS 
I.  G8neral  reaulrements 
1.  The  devices  must  be  designed  and  manufactured  in  such  a  way  that, 
when  used  under  the  conditions  and  for  the  purposes  Intended,  they 
will  not  compromise  the  clinical  condlt ion  or  the  safety  of  the 
patients,  users  and,  where  applicable,  other  persons.  The  rlsk.s 
associated  with  the  devices  must  be  reduced  to  an  acceptable  level 
compatible with  a  high  level  of  protection of  health  and  safety. 
2.  The  solutions  adopted  by  the  manufacturer  for  the  design  and 
construction  of  the  devices  must  conform  to  safety  principles, 
taking  account  of  the generally acknowledged  state of  the art. 
3.  The  devices  must  achieve  the  performances  Intended  by  the 
manufacturer,  I.e.  be  designed  and  manufactured  in  such  a  way  that 
they  are  suitable  for  one  or  more  of  the  functions  referred  to  In 
Article 1(2)(a),  as specified by  the manufacturer. 
4.  The  characteristics and  performances  referred  to  in  Sections  1  and  3 
must  not  be  adversely  affected  to  such  a  degree  that  the  clinical 
condition and  safety of  the  patients and,  where  applicable,  of other 
persons  are  compromised  during  the  I ifetime  of  the  device  as 
indicated  by  the  manufacturer,  when  the  device  is  subjected  to  the 
stresses which  can  occur  during  normal  conditions of  use. 
5.  The  devices  must  be  designed,  manufactured  and  packed  in  such  a  way 
that  their  characteristics  and  performances  during  their  intended 
use  are  not  adversely  affected  in  the  storage  and  transport 
conditions  (temperature,  humidity,  etc.)  laid  down  by  the 
manufacturer. 
6.  Any  undesirable  side-effects  must  constitute  acceptable  risks  when 
weighed  against  the  performances  Intended. - 44  -
11.  ReQuirements  regarding design and  construction 
7.  Chemical  and  phYsical  properties 
7.1  The  devIces  must  be  des lgned  and  manufactured  In  such  a  way  as  to 
guarantee  the  characteristics  and  performances  referred  to  In 
Section  on  the  "General  requirements".  Particular  attention  must 
be  pa ld  to: . 
the  choice of materials used,  particularly as  regards  toxicity 
and,  where  appropriate,  flammability; 
the  compatibility  between  the  materials  used  and  biological 
tissues,  cells and  body  fluids,  taking  account  of  the  Intended 
purpose  of  the  device. 
7.2  The  devices  must  be  designed,  manufactured  and  packed  in  such  a  way 
as  to  minimize  the  risk  posed  by  contaminants  and  residues  to  the 
persons  Involved  in  the  transport,  storage  and  use  of  the  devices 
and  to  the  patients,  taking  account  of  the  intended  purpose  of  the 
product.  Particular  attention  must  be  paid  to  the  tissues  exposed 
and  to  the  duration  and  frequency of exposure. 
7.3  The  devices  must  be  designed  and  manufactured  In  such  a  way  that 
they  can  be  used  completely  safely  with  the  materials,  substances 
and  gases  with  which  they  enter  Into  contact  during  normal  use  or 
routine  treatment. 
7.4  Where  a  device  incorporates,  as  an  Integral  part,  a  sub~tance which, 
If used  separately,  may  be  considered  to  be  a  medicinal  product,  as 
defined  In  Article  1  of  Directive 65/65/EEC,  and  whose  action  in 
combination  with  the  device  can  result  In  its  bioavai lability,  the 
safety,  quality  and  usefulness  of  the  substance  must  be  verified, 
taking  account  of  the  Intended  purpose  of  the  device,  by  analogy 
with  the  appropriate  methods  specified  In  Directive 75/318/EEC,  as 
last  amended  by  Directive 89/341/EEC. 
7.5  The  devices  must  be  designed  and  manufactured  In  such  a  way  as  to 
minimize  the  health  risks  posed  by  substances. leaking  from  the 
device  during  use. - 45  -
8.  Infection and  microbial  contamination 
8.1  The  devices  and  manufacturing  processes  must  be  designed  In  such  a 
way  as  to minimize  the  risk of  Infection  to  the  patient.  The  design 
must  allow  easy  handling  and,  where  necessary,  minimize 
contamination of  the  device  by  the  patient or  vice  versa  during use. 
8.2  Where  a  device  Incorporates  animal  or  human  tissues,  the  risks  of 
cross-Infection  must  be  minimized  by  selecting  appropriate  tissues 
and  using 
procedures. 
appropriate  Inactivation,  conservation  and  test 
8.3  Sterl le  devices  must  be  designed,  manufactured  and  packed  in  a 
non-reusab I  e  pack  and/or  accordIng  to  approprIate  procedures  to 
ensure  that  they  are  sterile  when  placed  on  the  market  and  remain 
sterl le,  under  the  storage  and  transport  conditions  laid  down,  until 
the  protective packaging  Is damaged  or  opened. 
8.4  Devices  labelled  sterile  must  have  been  sterilized  by  an 
appropriate,  validated method. 
8.5  Packaging  systems  for  non-sterile  devices  must  keep  the  product 
without  deterioration at  the  level  of cleanliness stipulated and,  If 
the  devices  are  to  be  sterll !zed  prior  to use,  minimize  the  risk of 
microbial  contamination. 
8.6  The  packs  and/or  label  of  the  device  must  distinguish  between 
Identical  or  similar  products  sold  In  both  sterile  and  non-sterile 
packaging. 
9.  Construction  and  environmental  properties 
9.1  If  the  device  Is  Intended  for  use  In  combination  with  other  devices 
or  equipment,  the  connection system must  be  safe and  must  not  impair 
the  specified  performances  of  the  devices.  Any  restrictions on  use 
must  be  Indicated on  the  label  or  In  the  Instruction  leaflet. - 46  -
9.2  Devices  must  be  designed  and  manuf~ctured  In  suqh  a  way  .as  to  remove 
or minimize  as  far  as  possible: 
the  risk  of  Injury,  In  connection  with- ~~elr  physical, 
Including  dimensional  features; 
risks  connected  with  reasonably  .foreseeable  environmental 
conditions,  such  as  magnetic  fields,  external  electrical 
Influences,  electrostatic discharge,  pressure or  variations  In 
pressure and  acceleration; 
the  risks of  Interference with  other  devices  normally  required 
for  the  Investigations or  for  the  treatment  given; 
rIsks  poss I  b I  y  arIsIng  from  I  ack  of  maintenance  and 
calibration,  Including: 
ageing  of  the materials used, 
loss of  accuracy  of  any  measuring  or  control  mechanism. 
9. 3  DevIces  must  be  desIgned  and  manufactured  In  such  a  way  as  to 
minimize  the  risks  of  fire  or  explosion  during  normal  use  and  in 
failsafe  condition.  Particular  attention  must  be  paid  to  devices 
which  must  be  exposed·  to  or  used  in  association  with .flammable 
substances or  substances which  could  cause  combustion. 
10.  Devices  with  a  measuring  function 
10.1  Devices  with  a  measuring  function  must  be  designed  and  manufactured 
In  such  a  way  as  to  provide  sufficient  accuracy_and  stability  as 
specified.  by  the. manufacturer,. taking  account  of  the  ·Intended 
purpose of  the  device. 
10.2  The  units  on  the  measurement;  monitoring  and  display  scale  must  be 
designed  In  line  with  ergonomic  principles,  taking  account  of  the 
Intended  purpose  of  the  device. 
10.3  The  measurements  made  by  devices  with  a  measuring  function  must  be 
expressed  In  legal  units 
Directive 80/181/EEc<1>, 
89/617/EEc(2). 
conformIng  to  the  provIsIons  of  Counc I I 
(1)  OJ  No  L  39,  15.2.1980,  p.  40. 
(2)  OJ  No  L  357,  7.12.19~9, p.  28. 
as  last  amended  by  Directive - 47  -
11.  Protection against  radiation 
11.1  The  devices  must  be  designed  and  constructed  In  such  a  way  that  the 
radiation  emitted  will  not  attain  dangerous  levels.  Where  emission 
of  dangerous  levels of  radiation  Is  necessary  for  a  specific medical 
purpose  considered  to outweigh  the  r·lsks  Inherent  In  the  emissions, 
It  must  be  possible  for  the user  to control  the emissions. 
11.2  Devices  emitting  Ionizing  radiation must  be  designed  and  constructed 
In  such  a  way  as: 
(a)  to  ensure  that  the  Quantity  and  Quality  of  radiation  emitted 
can  be  adjusted and  control led; 
(b)  to  reduce  exposure  of  the  user  at  work  and  a II  unnecessary 
exposure of  the patient. 
11.3  The  operating  Instructions  for  devices  emitting  radiation  must  give 
detailed  information  on  the  nature  of  the  devices,  means  of 
protecting  the  patient  and  user  and  on  ways  of  avoiding  mishandl lng 
and  the  risks  Inherent  In  Installation. 
11.4  Devices  emitting radiation must  be  designed  and  manufactured  In  such 
a  way  as  to  reduce  unnecessary  exposure  of  the  patient  and  of  the 
user  as  far  as  possible. 
11.5  Instruments,  apparatus  or  appliances  emitting  radiation .must  be 
fitted  with  visual  displays  and/or  audible  warnings  of  radiation 
emissions. 
12.  · Reau I  rements  for  medIca I  devIces  connected  to  or  equIpped  wIth  an 
energy  source 
12.1  Devices  depending  on  software  must  be  designed  In  such  a  way  as  to 
minimize  the  risks arls·lng  from  errors  in  the  program. 
12.2  DevIces  where  the  safety  of  the  patIents  depends  on  an  I  nterna I 
power  supply  must  be  equipped  with  a  means  of  determining  the state 
of  the  power  supply. - 48  -
12.3  Devices  where  the  safety  of  the  patients  depends  on  an  external 
·power  supply  must  Include  an  alarm  system  to  signal  any  power 
failure. 
12.4  Dev·lces  Intended  to  monitor  one  or  more  clinical  parameters  of  a 
patient  shall  be  equipped  wlt.h  appropriate  alarm  systems  to  alert 
the  user  of  situations  which  could  lead  to.  death  or  severe 
deterioration of  the patient's state of  health. 
12.5  The  devIces  must  be  desIgned  and  manufactured  In  such  a  way  as  to 
minimize  the  risks  of  creating  electromagnetic  fields  which  could 
impair  the operation of  other  devices or  equipment  In  the  vicinity. 
12.6  Protection against  electrical  risks 
The  devices  must  be  designed  and  manufactured  in  such  a  way  as  to 
avoid,  as  far  as  possible,  the  risk of electric shocks  during  normal 
use  and  Jn  single  fault  condition,  provided  the  devices  are 
Installed correctly.  ·. 
12.7  Protection against  mechanical  and  thermal  risks 
12.7.1. The  devices  must  be  designed  and  manufactured  In  such  a  way  as  to 
protect  the  pat lent  and  user  against  mechanical  r lsks  connected 
with,  for  example,  resistance,  stability and  moving  parts. 
12.7.2 The  devices  must  be  designed  and  manufactured  In  such  a  way  as  to 
reduce  to  the  lowest  possible  level  the  risks arising  from  vibration 
generated  by  the  devices,  taking  account  of  technical  progress  and 
of  the  means  available  for  limiting  vibrations·,  particularly  at 
source.  unless  the  vibrations are  part of  the specified  performance. 
12.7.3 The  devices  must  be  designed  and  manufactured  in .such  a  way  as  to 
reduce  to  the  lowest  possible  level  the  risks arising  from  the noise 
emitted,  taking  account  of  technical  progress  and  of  the  means 
available. to  reduce  noise,  particularly at  source,  unless  the  noise 
emitted  Is  part of  the  specified  perf~rmance. - 49  -
12.7,4 The  terminals  and  connectors  to  the  electricity,  gas  or  hydraulic 
and  pneumatic  energy  supplies  which  the  user  has  to  handle  must  be 
designed  and  constructed  In  such  a  way  as  to  minimize  all  possible 
risks. 
12.7.5 Accessible  parts  of  the  devices  and  their  surroundings  must  not 
attain potentially dangerous  temperatures under  normal  use. 
12.8  Protection against  the  risks posed  to  the  patient  bY  energy  suppl les 
or  substances 
12.8.1  Devices  for  supplying  the  patient  with  energy  or  substances  must  be 
designed  and  constructed  In  such  a  way  that  the  flow  rate can  be  set 
and  maintained  accurately  enough  to  guarantee  the  safety  of  the 
patient  and  of  the user. 
12.8.2 Devices  must  be  fitted  with  an  Interlock  and/or  alarm  system  to 
prevent  and/or  Indicate  any  Inadequacies  In  the  flow  rate  which 
could  pose  a  danger. 
12.9  The  function  of  the  controls  and  visual  displaYs  must  be  clearly 
specified on  the devices. 
13.  Information  supcl led  by  the manufacturer 
13.1  Each  device  must  be  accompanied  by  the  information  needed  to  use  it 
safely  and  to  Identify  the  manufacturer,  taking  account  of  the 
training and  knowledge  of  the  potential  users. 
This  Information  comprises  the  detai Is  on  the  label  and ·the  data  In 
the  Instruction  leaflet. 
As  far  as  practicable and  appropriate,  the  Information  needed  to use 
the  device  safely must  be  set out  on  the  device  Itself and/or  on  the 
packaging  for  each  unit  or,  where  appropriate,  on  the  sales 
packaging.  If  Individual  packaging of  each  unit  Is  not  practicable, 
the  Information  must  be  set  out  In  the  leaflet  suppl led  with  one  or 
more  devices. 
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An  Instruction  leaflet  must  be  included  In  the  packaging  for  every 
device. 
By  way  of  exception,  no  such  Instruction  leaflet  is  needed  for 
devices  In  Class  I  or  Class  lla  If  they  can  be  used  completely 
safely without  any  such  Instructions. 
13.2  Where  appropriate,  this  Information  should  take  the  form  of  symbols. 
Any  symbols  and  Identification  colours  used  must  conform  to·  tti'e 
harmonized  standards.  In  areas  for  which  no  standards  exist,  the 
symbols  and  colours  must  be  described  in  the  documentation  suppl led 
with  the  device. 
13.3  The  label  must  bear  the  following  particulars: 
(a)  the  name  or  trade  name  and  address of  the  manufa~turer; 
(b)  the  details  strictly  necessary  for  the  user  to  identify  the 
device  and  the  contents of  the  packaging; 
(c)  where  appropriate,  the  word  "STERILE"; 
(d)  where  appropriate,  the  batch  code,  preceded  by  the  word  "LOT", 
or  the serial  number; 
(e)  where  appropriate,  an  Indication  of  the  time  I imit  for 
completely safe use,  expressed  as  the  year  and  month; 
(f)  where  appropriate,  an  Indication  that  the  device  Is  for  single 
use; 
(g)  If  the  device  is  custom-made,  the words  "cust.om-made  device"; 
(h)  If  the  device  is  Intended  for  clinical  Investigations,  the 
words  "exclusively for  clinical  investigations"; 
(I}  any  special  storage  and/or .handling conditions; 
(J)  any  special  operating  instructions; 
(k)  any  warnings  and/or  precautions  to  take. - 51  -
13.4  If  the  Intended  purpose  of  the  device  Is  not  obvious  to  the  user, 
the  manufacturer  must  clearly  state  It  on  the  label  and  In  the 
Instruction  leaflet. 
13.5  Wherever  reasonable  and  practicable,  the  devices  and  detachable 
components  must  be  Identified,  where  appropriate  In  terms  of 
batches,  to  allow  all  appropr late  act ion  to  detect  any  potentIa I 
risk  posed  by  the  devices  and  detachable components.• 
13.6  Where  appropriate,  the  Instruction  leaflet  must  contain  the 
following  particulars: 
(a)  for  devices  In  Class  lib  or  Class  Ill  .  the  year  of 
authorization  to affix  the  EC  mark; 
(b)  the  detal Is  referred  to  In  Section  13.3,  with  the  exception of 
points  (d)  and  (e); 
(c)  the  performances  referred  to  In  Section  3  and  any  undesirable 
side-effects; 
(d)  If  the  device  must  be  Installed  with  or  connected  to  other 
medical ·devices  or  eQuipment  In  order  to  operate  as  reQuired 
for  Its  Intended  purpose,  sufficient  detai Is  of  its 
characteristics  to  Identify  the  correct  devices  or  equipment 
to use  In  order  to obtain  a  safe combination; 
(e)  a I I  the  Information  needed  to  verIfy  whether  the  devIce  Is 
properly  Instal led  and  can  operate  correctly  ~nd safely,  plus 
details of  the  nature  and  freQuency  of  the  maintenance  needed 
to  ensure  that  the  devices  operate  properly  and  safely  at  alI 
times; 
(f)  where  appropriate.  Information  to  avoid  certain  risks  In 
connection with  Implantation of  the device; 
(g)  Information  regarding  the  risks  of  reciprocal  Interference 
posed  by  the  presence  of  the  devIce  durIng  specIfIc 
Investigations or  treatment; - 52  -
(h).  the  necessary  Instruct Ions  In  the  event  of  damage  'to  the 
sterl ~~  packagln~  and,  where  appropriate,  detal Is  of 
appropr I  a,te  methods. of  rester I I I  zat I  on; 
(I)  If  the  device  Is,  reusable,  Information  on  the  appropriate 
processes  to  allow  reuse,  including  cleaning,  disinfect ion, 
~ackaglng  and,  w~ere ·appropriate,  rester I I lzatiOn,  and  any 
restriction on  the.number  of reuses; 
(J)  det~lls of  any  further  treatment  or  handling  needed  before  the 
device  can  be  used  (for  example,  sterilization,  final 
assembly,  etc.); 
{k)  In  the  case  of  devices  emitting 
purposes,  detai Is  of  the  nature, 
distribution of  this  radiation. 
radiation  for  medical 
type.  Intensity  and 
The  Instruction  leaflet must  also  Include  detai Is  allowing  the 
medlca.l  staff  to  brief  the  patient  on  any  contra-indications 
and  any  precautions  to  be  taken.  These  deta I Is  shou I  d  cover 
In  particular: 
(I)  precautlons  to  be  taken  In  the  event  of  changes  In  the 
performance of  the  device; 
(m)  .  precautIons  to  be  taken  as  regards  exposure.  In  reasonab I  y 
foreseeable  env~ronmental  conditions,  to  magnetic  fields, 
external  electrical  Influences,  electrostatic  discharge, 
pressure  or  variations  In  pressure,  acceleration,  thermal 
Ignition sources,  etc.; 
(n)  adequate  Information  regarding  the  medicinal  products  which 
the  device  In  question  is  designed  to administer; 
(o)  precautions  to  be  taken  against  any  special.  unusual  risks 
related  to  the  disposal  of  the  device. ' 
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,  ANNEX  2 
EC  DECLARATION  OF  CQNFORM!JY 
CFULL  QUALITY  ASSURANCE  SYSTEM) 
1.  The  manufacturer  sha II  app I  y  the  qua I I ty  system  approved  for  the 
desIgn,  manufacture  and  f Ina I  Inspect ion  of  the  products  concerned, 
as  spec if led  in  Sect ions  3  and  4,  and  shall  be  sub:Ject  to  the  EC 
surveil lance  specified  in  Section 5. 
2.  The  dec I  a rat I  on  of  conformIty  Is  the  procedure  whereby  the 
manufacturer  who  fulfils  the  obligations  imposed.  by  Section  1 
ensures  and  declares  that  the  products concerned  meet  the  provisions 
of  this Directive which  apply  to  them. 
The  manufacturer  shall  affix  the  EC  mark  In  accordance  with 
Article  17  and  shall  draw  up  a  written  declaration  of  conformity. 
This  declaration  shal I  cover  a  given  number  of  identified  specimens 
of  the  products  manufactured  and  shall  be  kept  by  the  manufacturer. 
The  EC  mark  shal I  be  accompanied  by  the  identification number  of  the 
notified body  which  performs  the  tasks  referred  to  in  this Annex. 
3.  Quality  system 
3.1  The  manufacturer  shall  lodge  an  application  for  assessment  of  his 
quality  system with  a  notified body; 
The  application shal I  include: 
the  name  and  address of  the manufacturer; 
all  the  relevant  information  on  the  product  or  product 
I 
category  covered  by  the  procedure; 
a  written declaration  that  no  application  has  been  lodged  with 
any  other  notified body  for  the same  products; 
the  documentation on  the quality system; 
an  undertaking  to  fulfi I  the  obi igations  i~posed  by  the 
quality  system  approved; 
I 
an  undertaking  to  keep  the  approved  quality  system  adequate 
and  efficacious; ··--& 
----------
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an  undertaking  by  the  manufacturer  to  Institute  and  keep 
updated  a  post-marketing  survel I lance  system.  This 
undertak 1  ng  sha II  1  nc lude  an  obI I  gat ion  for  the  manufacturer 
to notify  the  competent  authorities of  the  following  incidents 
Immediately  on  learning of  them: 
(I)  any  deterioration  In  the  characteristics  and/or 
/  __ ,....r--,.--
performances  of  a  device.  as  well  as  any  Inaccuracies  In 
the  Instruction  leaflet which  m~ght  lead  to or  might  have 
led  to  the  death  of  a  pat lent  or  user  or  to  a  serious 
deterioration  In  their  state of  health; 
,__.  .. · 
~  ... ~'  (il) any  technical  or  medical  reason  connected with  the  device 
1  ead i ng  to  reca 1  1  of  dev i cas  of  the  same  type  by  the 
manufacturer. 
3.2  Application  of  the  Quality  system  must  ensure  that  the  products 
conform  to  the  provisions  of  this  Directive  which  apply  to  them  at 
every  stage.  from  design  to  final  inspection.  All  the  elements, 
reQuirements  and  provisions  adopted  by  the  manufacturer  for  his 
Qua II ty  system  sha II  be  documented  in  a  systematIc  and  order I  y 
manner  in  the  form  of written policies and  procedures.  This  QUality 
system  documentation  must  permit  uniform  interpretation  of  the 
Quality  policies  and  procedures  such  as  Quality  programmes,  Quality 
plans,  Quality manuals  and  Quality  records. 
It  shall  include  in  particular  an  adeQuate  description of: 
(a)  the manufacturer's Quality objectives; 
(b)  the  organization of  the  business  and  in  particular: 
the  organizational  structures,  the  responsibilities  of 
the  managerial  staff  and  their  organizational  authority 
where  Quality  of  design  and  manufacture  of  the  products 
is concerned; - 55  -
the  methods  of  monItor lng  the  eff I  c lent  oper.at ion  of  the 
quality  system  and  In  particular  Its  ability  to  achieve 
the  desired  quality  of  design  and  of  product,  Including 
control  of  products which  fall  to conform; 
(c)  the  procedures  for  monitoring  and  verifying  the  design  of  the 
products  and  In  particular: 
a  general  description  of  the  product,  l~clud~ng  any 
variants planned; 
the  design  specifications,  Including  the  standards  whiCh~'­
wl  I I  be  appl led  and  a  description  of  the  solutions 
adopted  to  fulfi I  the  essential  requirements  which  apply 
to  the  products  If  the standards  referred  to  In  Article  5 
are  not  applied  in  full; 
the  techniques  used  to  control  and  verify  the  design  and 
the  processes  and  systematic  measures  which  wll I  be  used 
when  the  products are  being  designed; 
If  the  device  Is  to  be  connected  to  other  devlce(s)  In 
order  to operate as  Intended,  proof  must  be  provided  that 
It  conforms  to  the  essent I  a I  requIrements  when  connected 
to  any  such  device(s)  having  the  characteristics 
specified  by  the manufacturer; 
a  statement  Indicating  whether  or  not  the  device 
incorporates,  as  an  integral  part,  a  substance  as 
referred  to  In  Section 7.4  of  Annex  1  whose  action  in 
combination  with  the  device  may  resu!ft  In  its 
bioavai lability  and  data  on  the  tests  conducted  In  this 
connection; 
the  cl lnlcal  data  referred  to  in  Annex  10; 
the  draft  label  and,  where  appropriate,  lnstructlon 
leaflet; - 56  ,.... 
(d)  the  Inspection  and  quality  assur.ance  techniques  .at  the 
~anutacturlng stage  and  In  partlcu1ar: 
the  pro.c.esse.s  and  .Proc.edur  ~s  wh l.ch  w I I I  be  used, 
pa.rt 1  cuI ar 1  y  as  regards  s.t.er I I i zat ion,  purcha.s l·ng  and  the 
relevant  documents; 
the  product-Identification  procedures  drawn  up  and  kept 
up  ·to  da·te  from  .draw.lngs,  specf.fic.atlons  or  other 
relevant  documents  at  every  stage of  manufac.ture; 
---------·~ 
.//  (e)  ·the  appropriate  tests  and  trials  which  will  be  carried  out 
b.e·for:e,  dur lng  and  after manufacture,  the  frequency  wl th  whIch 
they will  take  place,  and  the  test  equipment  used;  it must  be 
·possi·bl·e  to  trace  back  the  .calibration of  the  test  equipment 
adequately. 
3.3  The  notl·fi.ed  body  shall  audit  the  quality  system  to  determine 
whether  It  meets  the  requirements  referred  to  in  Section  3.2.  It 
shall  presume  that  quality  systems  .which  Implement  the  rele,vant 
harmonized  standards  conform  to  these  requirements. 
The  assessment  team  sha I I  I nc.l ude  at  I east  one  member  w  I t h  past 
.ex per l.ence  of  assessments  of  the  techno logy  concerned.  The 
assessment  procedure  sha I I  l·nc I ude  an  inspect I on  on  the 
manufa.cturer's  premises  and,  in  dul.y  substantiated  cases,  on  the 
premises  of  the  manufacturer's  suppliers  to  inspec~  the 
manufacturing processes. 
The  decIsion  sha I I  be  not If  l·ed  to  the · manufacturer.  It  sha II 
contain  the  conclusions of  the  Lnspection  and  a  reasoned  assessment. 
3.4  The  manufacturer  shall  inform  t.he  notified  body  which  approved  the 
qua I I ty  system  of  any  pi an  for  subs·tant i a I  changes  to  the  qua II ty 
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The  notified body  shall  assess  the  changes  proposed  and  shall  verify 
whether  after  these  changes  the  Quality  system  wil I  stl I I  meet  the 
reQuirements  referred  to  in  Section3.2.  It  shall  notify  the 
manufacturer  of  Its  decision.  This  decision  shall  contain  the 
conclusions of  the  Inspection  and  a  reasoned  assessment. 
4.  Examination of  the  design of  the  product 
4.1  In  addition  to  the  obligations  imposed  by  Section  3,  the 
manufacturer  shal I  lodge  an  application  for  examination  o~ ~the 
- ~- ..._  ' 
design dossier  relating  to  the  product  which  he  plans  to manufacture 
and  which  fal Is  into  the  category  referred  to  in  Section  3.1. 
4.2  The  application  shall  describe  the  design,  manufacture  and 
performances  of  the  product  in  Question.  It  shal I  Include  the 
documents  needed  to  assess  whether  the  product  conforms  to  the 
reQuirements  of  this Directive,  as  referred  to  in  Section  3.2(c). 
4.3  The  notified  body  shal I  examine  the  application  and,  If  the  product 
conforms  to  the  relevant  provisions  of  this· Direct lve,  shall  issue 
the  applicant  with  an  EC  design-examination  certificate.  The 
notified body  may  reQuire  the  application  to be  completed  by  further 
tests  or  proof  to  allow  assessment  of  conformity  with  the 
reQuirements  of  the  Directive.  The  certificate  shall  contain  the 
conclusions of  the  examination,  the  conditions of  val idlty,  the  data 
needed  for  identification  of  the  approved  design  and,  where 
appropriate,  a  description of  the  intended  purpose of  the  pr~duct. 
4. 4  The  app I i cant  sha I I  inform  the  notified  body  whIch  issued  the  EC 
design-examination certificate of  any  significant  change  made  to  the 
approved  design.  Changes  to  the  approved  design  must  receive 
further  approval  from  the  notified  body  which  issued  the  EC 
design-examination  certificate  wherever  the  changes  could  affect 
conformity  with  the  essential  reQuirements  of  the  Directive  or  with 
the  conditions  prescribed  for  use  of  the  product.  This  additional 
approval  shall  take  the  form  of  a  supplement  to  the  EC 
design-examination certificate. r-=· 
1  -
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5.  surveillance 
5.1  The  aim  of  surveillance  Is  to  ensure  that  the  manufacturer  duly 
fulfils  the obligations  Imposed  by  the  approved  qual lty system. 
5.2  The  manufacturer  shall  authorize  the  notified  body  to carry out  all 
the  necessary  Inspections  and  shall  supp.ly  It. with  all  relevant 
Information,  In  particular: 
the documentation on  the quality  system; 
the  data stipulated  in  the  part  of  the quality system  relating 
to  design,  such  as  the  results  of  analyses,  calculations, 
tests, etc.; 
the  data stipulated  In  the part  of  the  quality system  relating 
to manufacture,  such  as  reports  concerning  Inspections,  tests, 
calibration  and  the  qual iflcat.lons  of  the  .staff  concerned, 
.etc. 
5.3  The  not If led  body  sha II  period lea lly  carry  out  appropr late 
Inspections  and  assessments  to  make  sure  that  the  manufacturer 
applies  the  approved  quality  system  and  shall  supply  the 
manufacturer  with  an  assessment  report. 
5.4  In  addition,  the  notified  body  may  pay  unannounced  visits  to  the 
manufacturer.  At  the  time  of  such  visits,  the  notified  body  may, 
where  necessary,  carry  out  or  ask  for  tests  In  order  to  check  that 
the  quality  system  is  working  properly.  It  shal I  provide  the. 
manufacturer  with  an  inspect ion  report  and,  if  a  test  has  been 
carried out,  with  a  test  report. 
6.  Administrative  provisions 
6.1  The  manufacturer  shall,  for  a  period  ending  at  least  five  years 
after  the  last  product  has  been  manufactured,  keep  at  the  disposal 
of  the  national  authorities: 
the declaration of  conformity; 
the  documentation  referred  to  In  the  fourth  Indent  of 
Section 3.1; 
the  ~hanges referred  to  in  Section 3.4; 6.2 
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- the documentation  referred  to  In  Section 4.2;  and 
the  decisions  and  reports  from  the  notified  body  as  referred 
to  In  Sections 3.3,  4.3,  4.4,  5.3 and  5.4. 
The  notified body  shall  communicate  to  the other  notified bodies alI 
relevant  Information  concerning  the Quality system approvals  Issued, 
refused or  withdrawn. 
7.  APplication  to devices  In  Classes  Ita and  lib 
---- 1n  line with  Article  11(2)  and  (3),  this Annex  may  apply  to products', 
In  Classes  !Ia and  lib,  subject  to  the  following  derogations: 
7.1  For  products  In  Class  I Ia,  by  way  of  derogat ton  from  the  f Ina I 
Indent  of  Section 3.1,  the  manufacturer  shall  undertake  to  notify 
the  competent  authorities  of  the  Incidents  referred  to  In  the 
abovementioned  Indent  Immediately  on  learning  of  them  and  to 
Institute  and  keep  updated  an  appropriate  Internal  system  for  this 
purpose. 
7.2  Section 4  shall  not  apply  to products  In  Classes  Ita and  lib. ------· 
1. 
2. 
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ANNEX  3 
EC  TYPE-EXAMINATION 
EC  type-examination  Is  the  procedure·  whereby  a  notified 
ascertains  and  certifies  that  a  representative  sample  of 
product I  on  coveted  fu If I Is  the  reI evant  provIsIons ·  of 
Directive. 
body 
the 
this 
The  app II cat I  on  . for  EC ·  type-exam I  nat Jon  sha II  be  · lodged  by  the 
manufacturer  or  by  his  authorized  representative  established  In  the 
COmmunity  with  a  notified body. 
The  appl !cation shal I  Include: 
·the  name  and  address  of  the  manufacturer  and  the  name  and 
address of  the  authorized  representative  if  the application  is 
lodged  by  the  representative; 
the  documentation  described  in  Section 3  needed  to assess  the 
conformity  of  the  representative  sample  of  the  production  in 
Quest ion,  hereinafter  referred  to  as  the  "type",  wl th  the 
reQuIrements  of  thIs  DIrectIve.  The  app I I  cant  sha II  make  a 
"type"  ava II able  to  the  not If led  body.  The  not If led  body  may 
reQuest  other  samples  as  necessary; 
a  written declaration  that  no  application  has  been  lodged  with 
any  other  notified body  for  the same  type. 
3.  The  documentation  must  allow  an  understanding  of  the  design,  the 
manufacture  and  the  performances  of  the  product.  The  documentation 
shall  contain  the  following  Items  in  particular: 
a  general  description  of  the  type,  including  any  variants 
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design  drawings,  methods  of  manufacture  envisaged,  In 
particular  as  regards  steri I ization,  and  diagrams  of 
components,  sub-assemblies,  circuits, etc.; 
the  descriptions  and  explanations  necessary  to  understand  the 
abovementioned  drawings  and  diagrams  and  the  operation of  the 
product; 
a  list  of  the  standards  referred  to  in  Article 5,  applied  in 
full  or  in  part,  and  descriptions of  the  solutions  adoptsd  to  .  -...__-
meet  the  essential  requirements  if  the  standards  referred  to  "-
in  Article 5  have  not  been  applied  in  ful I; 
the  results  of  ·the  design  calculations,  investigations, 
technical  tests, etc.  carried out; 
a  statement  Indicating whether  or  not  the  device  Incorporates, 
as  an  Integral  part,  a  substance  as  referred  to  in  Section 7.4 
of  Annex  1  whose  action  in  combination  with  the  device  may 
result  in  its bloavai lab! lity,  and  data on  the  tests conducted 
in  this connection; 
the  clinical  data  referred  to  in  Annex  10; 
the draft  label  and,  where  appropriate,  instruction  leaflet.  · 
4.  The  notified body  shall: 
4.1  examine  and  assess  the .·documentation  and  verIfy  that  the  type  has 
been  manufactured  J.n  conform! ty  wl th  that  document at ion;  it  sha II 
also  record  the  Items  designed  In  conformity  with  the  applicable 
provisions of  the standards  referred  to  in  Article 5·,  as well  as  the 
Items  not  designed  on  .the  basis  of  the  relevant  provisions  of  the 
abovementioned  standards; 
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4.2  carry  out  or ·ask  for  the  appropr late  -Inspect Ions  and  the  tests 
necessary  to  ver 1  fy  whether  the  solutions  .adopted  by  the 
manufacturer  meet  the  essential  requirements  of  ..  this  Directive  If 
the  standards  referred  to  In  Article 5  have  not  been  applied;  If 
the  device  Is  to be  connected  to other  devlce(s)  In  order  to operate 
as  Intended,  proof  must  be  provided  that  it  conforms  to  the 
. essential  reQuirements  when  connected  to  any  such  devlce(s)  having 
the characteristics specified by  the manufacturer; 
4 .. 3- \  carry  out  or  ask  for  the  appropriate  Inspections  and  the  tests 
__ /--
/  necessary  to verify whether,  If  the manufacturer  has  chosen  to  apply 
.  _/' 
~  the  relevant  standards,  these  have  actually  been  applied; 
4.4  agree  with  the  applicant  on  the  place  where  the  necessary 
inspections  and  tests will  be  carried out. 
5.  If  the  type  conforms  to  the  provisions  of  this  Directive,  the 
notified  body  shall  Issue  the  applicant  with  an  EC  type-examination 
certificate.  The  certificate shall  contain  the  name  and  address  of 
the  manufacturer,  the  conclusions  of  the  Inspection,  the  conditions 
of  validity  and  the  data  needed  for  Identification  of  the  type 
approved.  The  relevant  parts of  the  documentation  shall  be  annexed 
to  the certiffcate and  a  copy  shall  be  kept  by  the notified  body. 
6.  The  app I I  cant  sha I I  Inform  the  notIfIed  body  whIch  Issued  the  EC 
type-examination  certificate of  any  significant  change  made  to  the 
approved  product. 
Changes  to  the  approved  product  must  receive  further  approval  from 
the  notified  body  which  issued  the  EC  type-examination  certificate 
wherever  the  changes  may  affect  conformity  with  the  essential 
reQuirements  or  with  the  conditions  prescribed  for  use  of  the 
product.  This  new  approval  shall,  where  appropriate,  take  the  form 
of  a  supplement  to  the  Initial  EC  type-examination certificate. - 63  -
7.  Administrative orovlslons 
7.1  Each  notified  body  shall  communicate  to  the  other  notified  bodies 
all  relevant  Information  on  EC  type-examination  certificates  and 
supplements  Issued,  refused or  withdrawn. 
7;2  Other  notified  bodies  may  obtain  a  copy  of  the  EC  type-examination 
certificates  and/or  the  supplements  thereto.  The  annexes  to  the 
certificates shall  be  made  available  to  the  other  notified bodies  on 
reasoned  application,  after  Informing  the manufacturer. 
·. l 
.~ 
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ANNEX  4 
EC  VERIFICATION  : :~ ~  ..  : .r.. ~.  # 
1.  EC  ver 1  f 1  cat Jon  ·J s -the·. p_rocedure. whereby  the  manufacturer  or  hIs 
authorized  representative  established  In  the  Community  ensures  and 
dec lare.s.  that.  the  products  whIch  . have.  been  subjected  to  the 
procedure  set  out  In  Section  4  conform  to  the. type  described  In  the 
EC  type-examination  certificate  and  meet  the  requirements  of  this 
Directive which  apply  to  them. 
2.  The  manufacturer  sha II  take  a II  the  measures  necessary  for  the 
manufactur lng  process  to  ensure  that  the  products  conform  to  the 
type  described  In  the  EC  type-examination  certificate  and  to  the 
requirements of  the Directive which  apply  to  them.  Before  the start 
of  manufacture,  the  manufacturer  sha II  prepare  documents  defInIng 
the  manufacturing  process,  In  particular  as  regards  sterilization 
where·  necessary,  together  with  alI  the  routine,  pre-establ lshed 
provisions  to  be  Implemented  to  ensure  homogeneous  production  and, 
where  appropriate,  conformity  of  the  products  with  the  type 
described  In·  the  EC  type-examination  certificate  and  with  the 
requirements  of  this  Directive  which  apply  to  them.  The 
manufacturer  shall  affix  the  EC  mark  lh  accordance  with  Article 17 
and  shall  draw up  a  declaration of  conformity. 
3.  The  manufacturer  shall  undertake  to  inst Jtute  and  keep  updated  a 
post-marketing  surveillance  system.  This  undertaking  shall  Include 
an  obligation  for  the  manufacturer  to  notify  the  competent 
authorities  of  the  following  Incidents  Immediately  on  learning  of 
them: 
(I)  any  deter lor  at ion  In  the  character 1st ics  and/or  performances 
of  a  device,  as  well  as  any  Inaccuracies  In  the  instruct ion 
leaflet which  might  lead  to or  might  have  led  to  the  death  of 
a  patient or  user or  to  a  serious deterioration  In  their  state 
of health; 4. 
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(II)  any  technical  or  medical  reason  connected  with  the  device 
leading  to  recall. of  devices  of  the  same  type  by  the 
manufacturer. 
The  notified  body  shall  carry  out  the  appropriate  examinations  and 
tests  In  order  to  verifY  the  conformity  of  the  product  with  the 
requirements of  the  Directive either  by  examining  and  testing  every 
product  as  specified  in  Section 5  or  by  examining  and  testing 
products  on  a  statistical  basis  as  specified  in  Section 6,  at  the 
choice of  the manufacturer. 
5.  Verification by  examination and  testing of every  product 
5.1  Every  product  shall  be  examined  Individually  and  the  appropriate 
tests  defined  In  the  relevant  standard(s)  referred  to  In  Article 5 
or  equivalent  tests  shall  be  carried out  In  order  to  verify,  where 
appropriate,  the  conformity  of  the  products  with  the type  described 
In  the  EC  type-examination  certificate and  with  the  requirements  of 
the  Directive which  apply  to  them. 
5. 2  The  not If led  body  sha II  affIx,  or  have  affIxed,  Its  I  dent I fl cat Jon 
number  to  each  approved  product  and  shall  draw  up  a  written 
certificate of  conformity  relating  to  the  tests carried out. 
6.  Statistical  verification 
6.1  The  manufacturer  shall  present  the manufactured  products  in  the  form 
of  homogeneous  batches. 
6.2  A random  sample  shal I  be  taken  from  each  batch.  The  products which 
make  up  the  sample  shall  be  examined  Individually  and  the 
appropriate  tests defined  In  the  relevant  standard(s}  referred  to  in 
Article 5  or  equivalent  tests shall  be  carried out  to  verify,  where 
appropriate,  the  conformity  of  the  products  with  the  type  described 
In  the  EC  type-examination  certificate and  with  the  requirements  of 
the  Directive  which  apply  to  them  In  order  to  determine  whether  to 
accept or  reject  the batch. 
\:, 
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Statistical  control  of  products  will  be  based  on  attributes, 
entailing  a  samp.llng  system  ensuring  a  limit  quality  corresponding 
to  a  probability  of  acceptance  of  5%,  with  a  non-conformity 
percentage  of  between  3  and  7%.  The  sampl lng  method  shal I  be 
established  by  the  harmonized  standards  referred  to  In  Article 5, 
taking  account  of  the  specific  nature  of  the  product  categories  in 
question. 
If  the  batch  Is  accepted,  the  notified  body  shall  affix,  or  have 
affixed,  Its  Identification number  to.  each  product  and  shal I  draw  up 
a  written  certificate  of  conformity  relating  to  the  tests  carried 
out.  AI  I  products  in  the  batch  may  be  put  on  the  market  except  any 
In  the  sample  which  failed  to conform. 
If  a  batch  Is  rejected  the  competent  notified  body  shal I  take 
appropriate  measures  to  prevent  the  batch  from  being  placed  on  the 
market.  In  the event  of  frequent  rejection of  batches,  the  notified 
body  may  suspend  the statistical  verification. 
The  manufacturer  may,  on  the  responsibility  of  the  notified  body, 
affix  the  notIfIed  body's  i dent If i cat ion  number  during  the 
manufacturing  process. 
7.  Administrative Provisions 
The  manufacturer  or  the  manufacturer's  authorized  representative 
shall,  for  a  period  ending  at  least  five--years  after  the  last 
pr6duct  has  been  manufactured,  keep  at  the  disposal  of  the  national 
authorities: 
the  declaration of  conformity; 
the  documentation  referred  to  In  Section  2; 
the certificates referred  to  in  Sections 5.2 and  6.4. 
8.  Application  to  devices  in  Class  1  Ia 
In  line  with  Article  11(2),  this  Annex  may  apply  to  products  in 
Class  I Ia,  subject  to  the  following  derogations: - 67  -
8.1  By  way  of  derogation  from  Sections  1  and  2,  by  virtue  of  the 
declaration of  conformity  the manufacturer  ensures  and  declares  that 
the  products  In  Class  lla  are  manufactured  In  conformity  with  the 
technical  documentation  referred  to  In  Section  3 of  Annex  7  and  meet 
the  requirements of  this Directive which  apply  to  them. 
8.2  By  way  of  derogation  from  Sections  1,  2,  5  and  6,  the  verifications 
conducted  by  the  notified  body  are  Intended  td  confirm  the 
conformity  of  the  products  In  Class  lla  with  1he  technical 
documentation  referred  to  In  Section 3 of Annex  7. 
8.3  By  way  of  derogation  from  Section 3,  the  manufacturer  or  the 
manufacturer's authorized  representative established  In  the  European 
Community  undertake  to  notify  the  competent  authorities  of  the 
Incidents  referred  to  In  the  abovementioned  Section  Immediately  on 
learning  of  them  and  to  Institute  and  keep  updated  an  appropriate 
Internal  system  for  this purpose. 
\ 
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ANNEX  5 
EC  DECLARATION  OF  CONFORMITY 
<PRODUCTION  QUALITY  ASSURANCE> 
The  manufacturer  sha I I  app I  y  the  qua I I ty  system  approved  for  the 
manufacture  of  the  products  concerned  and  carry  out  the  final 
Inspection,  as  specified  In  Section  3,  and  shall  be  subject  to  the 
EC  surveillance referred  to  In  Section  4. 
2.  Th~  declaration  of  conformity  Is  the  part  of  the  procedure  whereby 
the  manufacturer  who  fulfils  the  obligations  Imposed  by  Section  1 
ensures and  declares  that  the  products  concerned  conform  to  the  type 
described  In  the  EC  type-examination  certificate  and  meet  the 
provisions of  this Directive which  apply  to them. 
The  manufacturer  shall  affix  the  CE  mark  In  accordance  with 
Article 17  and  shall  draw  up  a  written  declaration  of  conformity. 
This  declaration  shall  cover  a  given  number  of  Identified  specimens 
of  the  produ~ts manufactured  and  shal I  be  kept  by  the  manufacturer. 
The  CE  mark  shall  be  accompanied  by  the  Identification number  of  the 
notified body  which  performs  the  tasks  referred  to  In  this Annex. 
3.  QualitY  system 
3.1  The  manufacturer  shall  lodge  an  application  for  assessment  of  his 
qua II ty  system  wl th a  not if led  body. 
The  appl !cation shall  Include: 
the  name  and  address of  the manufacturer; 
all  the  relevant  Information  on  the  product  or  product 
category covered  by  the procedure; 
a  written declaration  that  no  application has  been  lodged  with 
any  other  notified body  for  the same  products; - 69  -
the  documentation on  the  quality system; 
an  undertaking  to  fulfi I  the  obligations  Imposed  by  the 
quality  system approved; 
an  undertaking  to  keep  the  approved  quality  s>:stem  adequate 
and  efficacious; 
where  appropr late,  the  technical  documentation· on  the  types 
approved  and  a  copy  of  the  EC  type-examination certificates; 
an  undertaking  by  the  manufacturer  to  lnstl~ute  and  keep 
updated  a  post-marketing  survel I lance  system.  This 
undertaking  shall  include  an  obi igat ion  for  the  manufacturer 
to notify  the  competent  authorities of  the  following  incidents 
Immediately  on  learning of  them: 
(I)  any  deterioration  In  the  characteristics  and/or 
performances  of  a  device,  as  wei  I  as  any  Inaccuracies  in 
the  lnstruction?leaflet which  might  lead  to or  might  have 
led  to  the  death  of  a  pat lent  or  user  or· to  a  serious 
deterioration  In  their state of  health; 
(I i)  any  technical  or  medical  reason  connected  with  the  device 
leading  to  recall  of  devices  of  the  same  type  by  the 
manufacturer. 
3.2  Application  of  the  Quality  system  must  ensure  that  the  products 
conform  to  the  type  described  in  the  EC  type-examination 
certificate.  All  the  elements,  reQuirements  and  provisions  adopted 
by  the  manufacturer  for  his  quality  system  shall  be  documented  In  a 
systematic  and  orderly  manner  in  the  form  of  written policies  and 
procedures.  This  quality  system  documentation  must  permit  uniform 
Interpretation  of  the  quality  policies  and  procedures  such  as 
qual Jty  programmes,  qual Jty  plans,  qual lty  manuals  and  Qual lty 
records. 
'  ', 
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It  shall  Include  In  particular  an  adequate description of: 
(a)  the manufacturer's quality objectives; 
(b)  the organization of  the  business  and  In  particular: 
the  organ I  za tIona I  structures,  the  res  pons I  b I I It I  es  of 
the  manager I  a I  staff  and  theIr  organ I  zat lona I  authority 
where  manufacture of  the  products  Is concerned; 
the  methods  of  monitoring  the  efficient  operation  of  the 
quality  system  and  in  particular  its ability  to  achieve 
the  desired  quality  of  product,  Including  control  of 
products which  fall  to conform; 
(c)  the  Inspection  and  quality  assurance  techniques  at  the 
manufacturing  stage  and  In  particular: 
the  processes  and  procedures  which  wl~l  be  used, 
particularly as  regards sterilization,  purchasing  and  the 
relevant  documents; 
the  product-Identification  procedures  drawn  up  and  kept 
up  to  date  from  drawings,  specifications  or  other 
relevant  documents  at  every stage of manufacture; 
(d)  the ·appropriate  tests  and  trials  which  wi  II  be  carried  out 
before,  during  and  after  manufacture,  the  frequency  with  which 
they will  take  place,  and  the  test equipment  used;  It  must  be 
possib.le  to  trace  back  the  calibration  of  the  test  equipment 
adequately. 
3.3  The  notified  body  shal I  audit  the  qual lty  system  to  determine 
whether  It  meets  the  requirements  referred  to  in  Section 3.2.  ·1t 
shall  presume  that  quality  systems  which  implement  the  relevant 
harmonized  standards conform  to  these  requirements. - 71  -
Include  at 
of  the 
The  assessment  team  sha I I 
experIence  of  assessments 
assessment  procedure  shall  Include 
least  one  member  with  past 
technology  concerned.  The 
an  Inspection  on  the 
manufacturer's  premises  and,  In  duly  substantiated  cases,  on  the 
premises  of  the  manufacturer's  suppliers  to  Inspect  the 
manufacturing processes. 
The  decision  shall  be  notified  to  the  manufacturer  after  the  final 
Inspection.  It  shall  contain  the  conclusions  of  the  Inspection  and 
a  reasoned  assessment. 
3.4  The  manufacturer  shall  Inform  the  notified  body  which  approved  the 
Qua I I ty  system  of  any  pI an  for  substantIa I  changes  to  the  Qua I I ty 
system. 
The  notified body  shall  assess  the  changes  proposed  and  shall  verifY 
whether  after  these  changes  the  quality  system  wi  II  still  meet  the 
requirements  referred  to  In  Section  3.2.  After  receiving  the 
abovementioned  Information  It  shall  notify  the  manufacturer  of  Its 
decision.  This  decision  shall  contain  the  conclusions  of  the 
Inspection  and  a  reasoned  assessment. 
4.  Surveillance 
4.1  The  aim  of  surveillance  Is  to  ensure  that  the  manufacturer  duly 
fulfils the obligations  Imposed  by  the  approved  Quality system. 
4.2  The  manufacturer  shall  authorize  the  notified  body  to carry  out  all 
the  necessary  Inspections  and  shall  supply  It  with  all  relevant 
Information,  In  particular: 
the  documentation  on  the  quality system; 
the  data stipulated  In  the  part of  the quality system  relating 
to manufacture,  such  as  reports  concerning  Inspections,  tests, 
calibration  and  the  qualifications  of  the  staff  concerned, 
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4.3  The  notified  body  shall  periodically  carry  out  appropriate 
Inspections  and  assessments  to  make  sure  that  the  manufacturer 
app I I  es  the  approved  qua I I ty  system  and  sha I I  supp I  y  the 
manufacturer  with  an  assessment  report. 
4.4  In  addition,  the  notified  body  may  pay  unannounced  visits  to  the 
manufacturer.  At  the  time  of  such  visits,  the  notified  body  may, 
where  necessary;  carry  out  or  ask  for  tests  In  order  to  check  that 
the  quality  system  Is  working  properly.  It  shal I  provide  the 
manufacturer  wIth  an  inspect I  on  report  and,  If  a  test  has  been 
carried out,  with  a  test  report. 
5.  Administrative  provisions 
5.1  The  manufacturer  shall,  for  a  period  ending  at  least  five  years 
after  the  last  product  has  been  manufactured,  keep  at  the  disposal 
of  the  national  authorities: 
the declaration of  conformity; 
the  ··documental ion  referred  to  in  the  fourth  indent  of 
Section 3.1; 
the  changes  referred  to  In  Section  3.4; 
the  documentation  referred  to  In  the  seventh  indent  of 
Section 3.1;  and 
the  decisions  and  reports  from  the  notified  body  as  referred 
to  In  Sections 4.3 and  4.4. 
5.2  The  notified body  shal I  communicate  to  the other  notified  bodies  at I 
relevant  Information  concerning  the quality  system  approvals  Issued, 
refused or  withdrawn. 
6.  Application  to devices  In  Class  lla 
In  line  with  Article 11(2),  this  Annex  may  apply  to  products  In 
. Class  II a,  subject  to  these  derogatIons: - 73  -
6.1  By  way  of  derogation  from  Sections  2,  3.1  and  3.2,  by  virtue of  the 
declaration of  conformity  the manufacturer  ensures  and  declares  that 
the  products  In  Class  Ita  are  manufactured  In  conformity  with  the 
technical  documentation  referred  to  In  Section  3 of  Annex  7  and  meet 
the  requirements of  this Directive which  apply  to  them. 
6.2  By  way  of  derogation  from  the  final  Indent  of  Section  3.1,  the 
manufacturer  shal I  undertake  to  notify  the  competent  authorities of 
the  Incidents  referred  to  In  the  abovementioned  Indent  Immediately 
on  learning of  them  and  to  Institute and  keep  updated  an  appropriate 
Internal  system  for  this purpose. I I . 
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ANNEX  6 
EC  DECLARATION  OF  CONFORMITY 
<PRODUCT  QUALITY  ASSURANCE> 
1.  The  manufacturer  shall  apply  the  Quality  system  approved  for  the 
final  Inspection  and  testing of  the  product,  as specified  in  Section 
3,  and  shall  be  subject  to  the  survei I lance  referred  to  in  Section 
4. 
2:  The  declaration  of  conformity  is  the  part  of  the  procedure  whereby 
the  manufacturer  who  fulfils  the  obligations  imposed  by  Section  1 
ensures  and  declares  that  the  products  concerned  conform  to  the  type 
described  In  the  EC  type-examination  certificate  and  meet  the 
provisions of  this Directive which  apply  to  them. 
The  manufacturer  shat I  affix  the  EC  mark  in  accordance  with 
Article  17  and  shalt  draw  up  a  written  declaration  of  conformity. 
This  declaration  shalt  cover  a  given  pumber  of  identified  specimens 
of  the  products  manufactured  and  shal I  be  kept  by  the manufacturer. 
The  CE  mark  shalt  be  accompanied  by  the  identification number  of  the 
notified body  which  performs  the  tasks  referred  to  in  this Annex. 
3.  Qua II ty  SYStem  /~-~ 
3.1  The  manufacturer  shall  lodge  an  application  for  assessment  of  his 
QUality  system  with  a  notified body. 
The  application shat I  Include: 
the  name  and  address of  the manufacturer; 
at I  the  relevant  Information  on  the  product  or  product 
category  covered  by  the  procedure; 
a  written declaration  that  no  application  has  been  lodged  with 
any  other  notified body  for  the same  products; - 75  -
the  documentation on  the  quality system; 
an  undertaking  to  fulfl I  the  obligations  imposed  by  the 
qual lty system  approved; 
an  undertaking  to  keep  the  approved  quality  system  adequate 
and  efficacious; 
where  approprIate,  the  techn I  ca I  document at ion  on  the  types 
approved  and  a  copy  of  the  EC  type-examination certificates; 
an  undertak lng  by  the  manufacturer  to  notIfy  the  competent 
authorities of  the  following  Incidents  Immediately  on  learning 
of  them: 
(I)  any  deterioration  In  the  characteristics  and/or 
performances  of  a  device,  as  wei  I  as  any  inaccuracies  in 
the  instruction  leaflet which  might  lead  to or  might  have 
led  to  the  death  of  a  patient  or  user·or  to  a  serious 
deterioration  in  t~eir state of  health; 
(II)  any  technical  or  medical  reason  connected with  the device 
leading  to  recall  of  devices  of  the  same  type  by  the 
manufacturer. 
3.2  Under  the  quality  system,  each  product  shall  be  examined  and  the 
appropriate tests defined  in  the  relevant  standard(s)  referred  to  In 
Article 5  or  equivalent  tests  shall  be  carried  out  to  ensure  that 
the  products  conform  to  the  type  described  in  the  EC 
type-examination  certificate  and  fulfi I  the  provisions  of  this 
Directive  which  apply  to  them.  AI  I  the  elements,  requirements  and 
provisions  adopted  by  the  manufacturer  shall  be  documented  In  a 
systematic  and  orderly  manner  in  the  form  of  written  measures, 
procedures  and  Instructions.  This  quality system documentation  must 
permit  uniform  interpretation  of  the  quality  programmes,  quality 
plans,  quality manuals  and  quality  records. 
.. , 
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It shall  include  in  particular  an  adequate  description of: 
the  quality  objectives  and  the  organizational  structure. 
responsibi I I ties  and  powers  of  the  managerial  staff  with 
regard  to  product  quality; 
the  examlnat Ions  and  tests  that  will  be  carr led  out  after 
manufacture;  It  must  be  possible  to  trace  back  the 
calibration of  the  test  equipment  adequately; 
the  methods  of  monitoring  the  efficient  operation  of  the 
Qua I I  ty  system; 
the  quality  records.  such  as  reports  concerning  inspections. 
tests.  calibration  and  the  qualifications  of  the  staff 
concerned.  etc. 
3.3  The  notified  body  shal I  audit  the  qual lty  system  to  determine 
whether  it  meets  the  requirements  referred  to  In  Section 3.2.  It 
shall  presume  that  Quality  systems  which  implement  the  relevant 
harmonized  standards conform  to  these  requirements. 
The  assessment  team  sha I I 
exper lence  of  assessments 
include  at 
of  the 
least  one  member  with  past 
technology  concerned.  The 
assessment  procedure  shal I  include  an  inspection  on  the 
manufacturer's  premises  and.  In  duly  substantiated  cases.  on  the 
premises  of  the  manufacturer's  suppl Iars  to  Inspect  the 
manufacturing processes. 
The  decision  shall  be  notified  to  the  manufacturer.  It  shall 
contain  the  conclusions of  the  Inspection  and  a  reasoned  assessment. 
3. 4  The  manufacturer  sha I I  Inform  the  notIfIed  body  which  approved  the 
Qua I I ty  system  of  any  pI an  for  substantIa I  changes  to  the  qua 1  i ty 
system. 
The  notified body  shal I  assess  the  changes  proposed  and  shall  verify 
whether  after  these  changes  the  quality  system  wll 1 sti II  meet  the 
requirements  referred  to  In  Section  3.2.  After  receiving  the 
abovementioned  Information  it  shall  notify  the  manufacturer  of  its 
decision.  This  decision  shal I  contain  the  conclusions  of  the 
Inspection and  a  reasoned  assessment. . J 
4. 
4.1 
.  4.2 
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Surve I I I  ance 
The  aim  of  surveillance  Is  to  ensure  that  the  manufacturer  duly 
fulfils  the obligations  Imposed  by  the  approved  quality system. 
The  manufacturer  shall  allow  the  notified  body  entrance  for 
Inspection  purposes to the  Inspection,  testing and  storage  locations 
and  shall  supply  It  with all  relevant  Information,  In  particular: 
the  documentation on  the quality system; 
the  technical  documentation; 
the  quality  records,  such  as  reports  concerning  Inspections, 
tests,  calibration  and  the  qualifications  of  the  staff 
concerned,  etc . 
4.3  The  notified  body  shall  periodically  carry  out  appropriate 
Inspections  and  assessments  to  make  sure  that  the  manufacturer 
appl les  the quality  system  and  shall  supply  the manufacturer  with  an 
assessment  report. 
4.4  In  addition,  the  notified  body  may  pay  unannounced  visits  to  the 
manufacturer.  At  the  time  of  such  visits,  the  notified  body  may, 
where  necessa~y.  carry  out  or  ask  for  tests  In  order  to  check  that 
the  quality  system  is  working  properly  and  that  the  production 
conforms  to  the  requirements of  the  Directive which  apply  to  it.  To 
this end,  an  adequate  sample  of  the  final  products,  taken on  site by 
the  notified  body,  shall  be  examined  and  the  appropriate  tests 
defined  in  the  relevant  standard(s)  referred  to  In  Article 5  or 
equivalent  tests  shall  be  carried  out.  Where  one  or  more  of  the 
samples  fai Is  to  conform,  the  notified  body  shal I  take  the 
appropriate  measures.  It  shall  provide  the  manufacturer  with  an 
Inspection  report  and,  if  a  test  has  been  carried  out,  with  a  test 
report. - 78  -
5.  Administrative orovlslons 
5.1  The  manufacturer  shall,  for  a  period  ending  at  least  five  years 
after  the  last  product  has  been  manufactured,  keep  at  the  disposal 
of  the national  authorities: 
the declaration of  conformity; 
the  documentation  referred  to  In  the  seventh  Indent  of 
Section 3.1; 
the changes  referred  to  In  Section 3.4;  and 
the  decisions  and  reports  from  the  notified  body  as  referred 
to  In  the  final  Indent  of  Section 3.4 and  in  Sections  4.3  and 
4.4. 
5.2  The  notified body  shall  communicate  to  the other  notified bodies all 
relevant  Information concerning  the quality system  approvals  Issued, 
refused or  withdrawn. 
6.  Application  to  devices  in  Class  I Ia 
·In  line  with  Article 11{2),  this  Annex  may  apply  to  products  In 
Class  lla,  subJect  to  this derogation: 
6.1  By  way  of  derogation  from  Sections 2,  3.1  and  3.2,  by  virtue of  the 
declaration of  conformity  the manufacturer  ensures  and  declares  that 
the  products  In  Class  lla  are  manufactured  in  conformity  with  the 
technical  documentation  referred  to  In  Section 3 of  Annex  7  and  meet 
the  requlrements·of  this Directive which  apply  to  them. - 79  -
ANNEX  7 
EC  DECLARATION  OF  CQNFORMITY 
1.  The  EC  declaration  of  conformity  Is  the  procedure  whereby  the 
manufacturer  or  his  authorized  representative  established  In  the 
CommunIty  who  fu If II s  the  obI igat Ions  imposed  by  Sect ion  2  and,  in 
the  case  of  sterile products  and  measuring  devices,  the obligations 
imposed  by  Sectlon 5  ensures  and  declares  that  the  products 
concerned meet  the  provisions of  this Directive which  apply  to  them. 
The  manufacturer  may  affix  the  CE  mark  to each  product  In  accordance 
with  Article  11.  The  manufacturer  shall  draw  up  a  written 
declaration of  conformity. 
2.  The  manufacturer  shall  establish  the  technical  documentation 
described  in  Section 3.  The  manufacturer  or  his  authorized 
representative  established  in  the  Community  shall  keep  this 
documentation,  including  the  declaration  of  conformity,  at  the 
disposal  of  the  national  authorities  for  Inspection  purposes  for  a 
period  ending  at  least  five  years  after  the  last  product  has  been 
manufactured. 
Where  neither  the  manufacturer  nor  his authorized  representative are 
established  In  the  Community,  this obligation  to  keep  the  technical 
documentation  available  ~hall  be  the  responsibility  of  the  person 
who  places  the  product  on  the  Community  market. 
3.  The  technical  documentation  must  allow  assessment  of  the  conformity 
of  the  product  with  the  reQuirements  of  the  Directive.  It  shall 
include  In  particular: 
a  general  description  of  the  product,  including  any  variants 
planned; 
design drawings,  methods  of  manufacture  envisaged  and  diagrams 
of  components,  sub-assemblies,  circuits, etc.; - 80  -
the  descriptions  and  explanations  necessary  to  understand  the 
abovementioned  drawings  and  diagrams  and  the  operation of  the 
product; 
a  1  1st  of  the  standards  referred  to  In  Article 5,  appl led  In 
full  or  In  part,  and  descriptions of  the  solutions  adopted  to 
meet  the  essential  requirements  of  the  Directive  If  the 
standards  referred  to  In  Article  5  have  not  been  appt led  In 
fu II; 
In  the  case  of  sterile products,  a  description  of  the  methods 
used; 
the  results of  the  design  calculations  and  of  the  Inspections 
carried  out,  etc.  If  the· device  Is  to  be  connected  to  other 
device(s)  In  order  to  operate  as  Intended,  proof  must  be 
provided  that  It  conforms  to  the  essential  requirements  when 
connected  to  any  such  dev I  ce(s)  havIng  the  characterIstIcs 
specified by  the manufacturer; 
the  test  reports and,  where  appropriate,  clinical  data. 
4.  The  manufacturer  sha II  take  a II  the  measures  necessary  for  the 
manufacturing  process  to  ensure  that  the  products  manufactured 
conform  to  the  technical  documentation  referred  to  in  Section  3  and 
to  the  requirements of  the  Directive which  apply  to  them. 
5.  In  the  case  of  products  placed  on  the  market  in  sterile  condition 
and  of measuring  devices,  the manufacturer  must  observe not  only  the 
provisions  laid  down  In  this  Annex  but  also  one  of  the  procedures 
referred  to  in  Annexes  4,  5  or  6.  Application of  the  abovementioned 
Annexes  and  the  Intervention  by  the  notified  body  shal I  be  I lmlted 
to: 
In  the  case  of  sterl le  products,  only  the  aspects  of 
manufacture  concerned  with  obtaining sterile conditions; 
in  the  case  of  measuring  devices,  only  the  aspects  of 
manufacture  concerned  with  the  conformity of  the  products with 
the metrological  requirements. 
Section 6.1  of  this Annex  shai 1 apply. - 81  -
6.  Application  to devices  In  Class  lla 
In  line  with  Article  11(2).  this  Annex  may  apply  to  products  ln 
Class  lla,  subject  to this derogation: 
6.1  Where  this  Annex  Is  appl led  In  conjunction  with  the  procedure 
referred  to  In  Annex  4,  5  or  6,  the  declaration  of  conformity 
referred  to  In  Section  1  of  this  Annex  and  the  declaration  of 
conformity  referred  to  In  the  other  abovementioned  Annexes  shall 
form  a  single declaration.  As  regards  the declaration based on  this 
Annex,  the  manufacturer  sha I I  ensure  and  dec I  are  that  the  product 
design meets  the  provisions of  this Directive which  apply  to  it. - 82  -
STATEMENT  CONCERNING  DEVICES 
FOR  SPECIAL  PURPOSES 
ANNEX  8 
1.  For  custom-made  devices  or  for  devices  intended  for  cl inlcal 
investlgatio~s  the  manufacturer  or  his  authorized  representative 
established  in  the  Community  shall  draw  up  the  statement  containing 
the  Information stipulated  In  Section 2. 
2.  The  statement  shal I  contain  the  following  information: 
2.1  For  custom-made  devices: 
data  allowing  identification of  the device  in  question; 
a  statement  that  the  device  is  Intended  for  exclusive use  by  a 
particular patient,  together  with  the  name  of  the  patient; 
the  name  of  the  medical  specialist  or  other  authorized  person 
who  made  out  the  prescription  and,  where  appl !cable,  the  name 
of  the clinic concerned; 
the  particular  features  of  the  device  as  specified  in  the 
relevant  medical  prescription; 
a  statement  that  the  device  in  question  conforms  to  the 
essential  requirements  set  out  In  Annex  1  and,  where 
applicable,  Indicating  which  essential  requirements  have  not 
been  fully met,  together  with  the grounds. 
2.2  For  devices  intended  for  the  clinical  investigations  covered  by 
Annex  10: 
data  allowing  identification of  the  device  in  question; 
an  Investigation plan stating  in  particular  the  purpose,  scope 
and  number  of  devices concerned; 
the  opinion  of  the  Ethics  Committee  concerned  and  details  of 
the  aspects covered  by  its opinion; - 83  -
the  name  of  the  medical  specialist  or  other  authorized  person 
- and  of  the  Institution responsible  for  the  lnve_stlgations; 
the  place,  starting  date  and  scheduled  duration  for  the 
Investigations; 
a  statement  that  the  device  In  question  conforms  to  the 
essential  requirements  apart  from  the  aspects  covered  by  the 
investigations  and  that,  with  regard  to  these  aspects,  every 
precaution  has  been  taken  to  protect  the  health  and  safety of 
the  pat lent. 
3.  The  manufacturer  shall  also  undertake  to  keep  available  for  the 
competent  national  authorities: 
3.1  For  custom-made  devices,  documentation  allowing  an  understanding  of 
the  design,  manufacture  and  performances  of  the  product,  including 
the  expected  performances,  so  as  to  allow  assessment  of  conformity 
with  the  requirements of  this Directive. 
The  manufacturer  sha I I  take  a I I  the  measures  necessary  for  the 
manufacturing  process  to  ensure  that  the  products  manufactured 
conform  to  the  documentation mentioned  in  the  first  paragraph. 
3.2  For  devices  intended  for  clinical  Investigations,  the  documentation 
shal I  contain: 
a  general  description of  the  product; 
design  drawings,  methods  of  manufacture  envisaged,  in 
particular  as  regards  steri I lzatlon, 
components,  sub-assemblies,  circuits, etc.; 
and  diagrams  of 
the  descriptions  and  explanations  necessary  to  understand  the 
abovementioned  drawings  and  diagrams  and  the  operation  of  the 
product; 
a  list  of  the  standards  referred  to  in  Article 5,  appl led  in 
ful I  or  in  part,  and  descriptions  of  the  solutions  adopted  to 
meet  the  essential  requirements  of  this  Directive  If  the 
standards  referred  to  in  Article 5  have  not  been  appl led; 
the  results of  the  design calculations,  and  of  the  inspections 
and  technical  tests carried out,  etc. - 84  -
The  manufacturer  shal I  take  all 
manufacturing  process  to  ensure 
the  measures  necessary  for  the 
that  the  products  manufactured 
conform  to  the  documentation  referred  to  In  the  first  paragraph  of 
this Section. 
The  manufacturer  may  authorize  the  assessment~  or  audit  where 
necessary.  of  the effectiveness of  these measures. - 85  -
ANNEX  9 
CLASSIFICATION  CRITERIA 
I.  CLASSIFICATION  RULES 
1.  Non-Invasive  devices 
1 .1  Ru 1  e  1 
AI  I  non-Invasive devices are  in  Class  I,  unless one  of  the  rules set 
out  hereinafter  appl les. 
1.2  Rule  2 
All  non-invasive  devices  intended  for  channel ling  or  storing  blood, 
body  I iQuids  or  tissues,  I iQuids  or  gases  for  the  purpose  of 
eventual  infusion,  administration  or  introduction  into  the  body  are 
In  c I  ass  I I  a: 
1.3  Rule  3 
If  they  are connected  to an  active medical  device  In  Class  lla 
or  a  higher  class; 
if  they  are  used  for  storing  blood  or  other  body  liQuids  or 
tissues. 
In  alI  other  cases  they are  In  Class  I. 
All  non-invasive  devices  intended  for  modifying  the  biological  or 
chemical  composition  of  blood,  other  body  I iQuids  or  other  I iQuids 
intended  for  Infusion  into  the  body  are  in  Class  lib,  unless  the 
treatment  consists  of  filtration,  centrifugation  or  exchanges  of 
gas,  heat  or  solute,  in  which  case  they  are  in  Class  lla. - 86  -
1.4  Rule  4 
All  non-Invasive  devices  which  come  Into  contact  with  Injured  skin 
are  In  c I  ass  If  they  are ·Intended  to  be  used  as  a  mechan i ca 1 
barr ler,  for  compress ion,  for  the  absorption  of  exudates  or  for 
moisture  permeability. 
They  are  In  Class  lib  If  they  are  Intended  to  be  used  principally 
for  third-degree  burns or other skin  injuries of  comparable  degree. 
In  all  other  cases  they  are  In  Class  lla. 
2.  Invasive devices 
2.1  Rule  5 
All  Invasive  devices  with  respect  to  body  orifices,  other  than 
surg I  ca I I  y  InvasIve  devIces  and  whIch  are  not  Intended  for 
connection  to an  active medical  device: 
are  In  Class  I  If  they are  Intended  for  transient  use; 
are  In  Class  I Ia  If  they  are  Intended· for  short-term  use, 
except  If  they  are  used  In  the  ora I  cavity  as  far  as  the 
pharynx,  In  the anterior  nostrils or  the external  ear  canal  up 
to the ear  drum,  In  which  case  they  are  In  Class  I; 
are  In  Class  I Ia  If  they are  Intended  for  long-term use. 
All  Invasive  devices with  respect  to body  orifices. other  than 
surgically  Invasive  devices  Intended  for  connection  to  an 
active  medical  device  In  Class  lla  or. a  higher  class.  are  In 
Class  lla. 
2.2  Rule  6 
All  surgically  Invasive  devices  Intended  for  transient  use  are  in 
Class  lla unless  they  are: - 87  -
Intended  to diagnose,  monitor  or  correct  a  defect  of  the.  heart 
or  of  the  central  circulatory  system  through  direct  contact 
with  these  parts  of  the  body,  In  which  case  they  are  In 
Class  Ill; 
2.3  Rule  7 
reusable  surgical  Instruments,  In  which  case  they  are  In 
Class  I. 
All  surgically  invasive  devices  intended  for  short-term  use  are  In 
Class  Ita unless  t~ey are  Intended: 
either  to  diagnose,  monitor  or  correct  a  defect  of  the  heart 
or  of  the  centra I  c I rcu I  a tory  system  through  dIrect  contact 
with  these  parts  of  the  body,  in  which  case  they  are  In 
Class  II  t; 
or  for  use  in  direct  contact  with  the  central  nervous  system, 
In  which  case  they  are  In  C1ass  Ill. 
2.4  Rule  8 
All  Implantable  devices  and  long-term  surgically  invasive  devices 
are  in  Class  I lb  unless  they  are  intended: 
to  be  placed  In  the  teeth,  in  which  case  they  are  In 
Class  lla; 
to  be  used  In  direct  contact  with  the  heart,  the  central 
circulatory  system  or  the  central  nervous  system,  In  which 
case  they are  In  Class  Ill; 
to  undergo  chemical  change  in  the  body,  to  be  biologically 
active,  to  be  wholly  or  mainly  absorbed,  to  supply  energy  in 
the  form  of  ionizing  radiation or  to  administer  medicines,  in 
which  case  they  are  in  Class  Ill,  except  If  the  devices  are 
placed  In  the  teeth. - as·  -
3.  Active  devices 
. Rule  9  ,;•  .• 
All  active  therapeutica,l  .de.vices  intended  to  supply  energy  or  to 
adm 1  n 1  ster.  samp I e  or  exchange  substances  are  In  C I ass  I I a  un I ess 
they  are  intended: 
to  administer  potentially  dangerous  l~vels or  forms  of  ene~gy 
to  the  human  body.  talc lng  account  of  the  par.t  of  the  body 
.  absorbing  the  energy  and/or  the  density of.the energy; 
to  administer  or  exchange  medicines,  body  I iQUids  or  other 
substances  in  a  potentially  dangerous  way,  .taking  account  of 
the  nature  of  the  substances  administered  and  of  the  part  of 
the  bod~ concerned,  or  in  such  a  way  that  the  exchange  or  flow 
cannot  be  controlled by  the  patient. 
In  these  cases.  the  devices  are  in  Class  lib.  All  active 
devices  intended  to  cont ro I  and  monitor  the  performance  of 
active  therapeutical  devices  in Class  lib or  intended directly 
to  influence  the  performance of  such  devices  are  in Class  I lb. 
3.2  Rule  10 
All  active devices  intended  for  diagnosis  are  in  Class  lla: 
if  they  are  intended  to  supply  energy  which  wll I  be  absorbed 
by·.  the  human  body,  except  for  devices  used  to- illuminate  the 
patient's body,  in  the  visible  spectrum; 
if  they  are  intended  primarily  to  allow  direct  diagnosis  of 
vital  physiological  processes  in  a  situation  posing  an 
immediate  danger  to  the  patie_nt's  J ife. 
3.3  Rule  11 
All  other  active  devices  are  in Class  I. - 89  -
4.  Special  rules 
4.1  Rule  12 
All  devices  Incorporating,  as  an  Integral  part,  a  substance  which, 
If  used  separately,  can  be  considered  to  be  a  medicinal  product,  as 
defined  In  Article  1  of  Directive 65/65/EEC,  and  whose  action  In 
combination with  the  devices  can  result  in  its  bloaval lability,  are 
In  Class  Ill. 
4.2  Rule  13 
All  devices  used  for  contraception  or  the  prevention  of  the 
transmission of  a  viral  disease  by  sexual  contact  are  in  Class  I lb. 
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II.  DEFINITIONS  AND  IMPLEMENTING  RULES 
1.  DEFINITI.ONS  FOR  THE  CLASSIFICATION  RULES 
1.1  Duration 
Transient  Normally  Intended  for  con~lnuous  use  for  less  than  so 
minutes. 
Short  term 
Long  term 
Norma I I y  Intended  for  contInuous  use  for  not  more 
than  30  days. 
Norma I I y  Intended  for  cont I nuous  use  for  more  than 
30  days. 
1.2  Invasive  devices 
Invasive  device  A  device  which.  In  whole  or  In  part.  penetrates 
Ins  I de  the  body.  eIther  through  a  body  orIfIce  or 
through  the  surface of  the  body. 
BodY  orifice  Any  natural  opening  In  the  body.  Including  the 
ex terna I  surf  ace  of  the  eyeba I I •  or  any  permanent 
artificial opening.  such  as  a  stoma. 
Surgically  Invasive 
device  A  device  which  penetrates  Inside  the  body  through 
the  surface  of  the  body.- with  the  aid  or  In  the 
context  of  a  surgical  operation. 
1.3  Reusable  surgical 
Instrument  Instrument  Intended  for  a  surgical  operation  such  as 
cutting. drilling.  sawing.  scratching.  retracting or 
clipping  without  connection  to  any  other  medical 
devIce  and  wh lch  can  be  used  In  sever  a I  dIfferent 
operation!. 1.4  Active medical 
device 
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Any  medical  device  connected  to  or  equipped  with  a 
source  of  electrical  energy  or  any  source  of  power 
other  than  that  directly generated by  the  human  body 
or  gravity and  which  acts  by  converting this energy. 
Medical  devices  Intended  to  transmit  energy, 
substances  or  other 
medical  device  and 
elements  between  an  active 
the  patient,  without  any 
significant  change,  are  not  considered  to  be  active 
medical  devices. 
1.5  Active  therapeutical 
device  Any  active  medical  device,  whether  used  alone  or  In 
combination  with  other  medical  devices,  to  support, 
modify  or  replace biological  functions or  structures 
with  a  view  to  treatment  or  alleviation  of  an 
Illness,  Injury or  handicap. 
1.6  Active  device  for 
diagnosis  Any  active  medical  device,  whether  used  alone  or  In 
combination  with  other  medical  devices,  to  supply 
Information  for  detecting,  diagnosing,  monitoring or 
treating physiological  conditions,  states of  health, 
II lnesses or  congenital  deformities. 
1.7  Central  circulatory 
system 
1.8  Central  nervous 
system 
The  following  vessel~: 
arterlae  pulmonales,  aorta  ascendens,  arterlae 
coronarlae,  arteria  carotls  communis,  arteria 
carot Is  ex terna,  arterIa  carot Is  I  nterna,  ar ter i ae 
cerebrales,  truncus brachlocephallcus,  venae  cordis, 
venae  pulmonales,  vena  cava  superior,  vena  cava 
inferior. 
Brain and  spinal  cord .. i 
I • 
I 
r . 
2. 
2.1 
2.2 
2.3 
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IMPLEMENTING  RULES 
App II cat ion  of  the  c I  ass If I  cat I  on  rules  sha II  be  governed  by  the 
Intended  purpose of  the devices.· 
1  f  the  devIce  1  s  Intended  to  be  used  In  comb I  nat I  on  wl th  another 
device.  the  classification  rules  shall  apply  separately  to  each  of 
the devices. 
If  the  device  Is  not  Intended  to  be  used  solely or  principally  In  a 
specific  part  of  the  body,  It  must  be  considered  and  classified on 
the basis of  the most  critical use. 
2. 4 ·  · 1  f  two  ru I  es  app.l y  to  the  same  devIce,  based  on  the  performance 
specified  for  the  device  by  tha manufacturer,  the  rule  resulting  In 
the  higher  classification shall  apply. 
i (• ·.All 1. 
1.1 
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ANNEX  10 
CLINICAL  EVALUATION 
General  Provisions 
As  a  general  rule.  confirmation of  conformity  with  the  requirements 
concerning  the  characteristics  and  performances  referred  to  In 
Sect I  on  1  of  Annex  1  under  the  norma I  condItIons  of  use  of  the 
device  and  the  evaluation  of  the  undesirable  side-effects  must  be 
based  on  clinical  data  In  the  case  of  Implantable  devices,  devices 
In  Class  Ill  and,  where  justified, other  devices.  Taking  account  of 
any  relevant  harmonized  standards,  where  appropriate,  the  adequacy 
of  the clinical  data shall  be  based on: 
1.1.1  either  a  compilation of  the  relevant  scientific  literature currently 
available  on  the  intended  purpose  of  the  device  and  the  techniques 
employed  as  well  as,  If  appropriate,  a  written  report  containing  a 
critical  evaluation of  this compilation; 
1.1.2  or  the  results  of  all  the  clinical  Investigations  made,  including 
those carried out  In  conformity with  Section  2. 
1.2  All  the  data  must  remain  confidential,  In  conformity  with  the 
provisions of Article 20. 
2.  Clinical  Investigation 
2.1  ObJectives 
The  objectives of  clinical  Investigation are: 
to  verify  that,  under  normal  conditions  of  use,  the 
performances  of  the  devices  conform  to  those  referred  to  in 
Section 3 of Annex  1;  and 
to  determine  any  undesirable  side-effects,  under  normal 
conditions  of  use,  and  assess  whether  they  are  risks  when 
weighed  against  the  Intended  performance  of  the  device. 
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2.2  Ethical  considerations 
Clinical  Investigations shall  be  carried out  In  accordance  with  the 
Helsinki  Declaration  adopted  by  the  18th  World  Medical  Assembly  in 
Helsinki.  Finland,  In  1964,  as  last  amended  by  the  41st  World 
Medical  Assembly  In  Hong  Kong  In  1989.  It  Is  mandatory  that  all 
measures  relating  to  the  protection  of  human  subjects  are  carried 
out  In  the  spirit  of  the  Helsinki  Declaration.  This  shall  Include 
every step  In  the clinical  Investigation  from  first  conslderation·of 
the  need  and  justification  of  the  study  to  publ lcatlon  of  the 
results. 
2.3  Methods 
2.3.1  Cl lnlcal  Investigations  shall  be  performed  on  the  basis  of  an 
appropriate  plan of  Investigation  corresponding  to  the  state of  the 
art  and  defined  In  such  a  way  as  to  confirm  or  refute  the 
manufacturer's  claims  for  the  device;  these  Investigations  shall 
Include  an  adeQuate  number  of  observations  to  guarantee  the 
scientific val ldlty of  the  conclusions. 
2.3.2  The  procedures  used  to  perform  the  Investigations  shall  be 
appropriate  to  the device under  examination. 
2.3.3  Clinical  Invest I  gat Ions  shall  be  performed  In  circumstances  similar 
to  the  normal  conditions of use  of  the device. 
2.3.4  All  the  appropriate  features.  Including  those  Involving  the  safety 
and  performances  of  the  device,  and  Its effect  ~n patients  shal 1  be 
examined. 
2.3.5  All  adverse  Incidents shall  be  fUlly  recorded. 
2.3.6  The  Investigations  shall  be  performed  under  the  responsibility of  a 
medical  specialist  or  another  authorized  Qualified  person  In  an 
appropriate environment. 
The  medical  specialist  or  other  authorized  person  shall  have  access 
to  the  technlca~ and  clinical  data  regarding  the device. - 95  -
2.3.7  The  written  report,  signed  by  the  medical  special 1st  or  other 
authorized  person  responsible,  shall  contain  a  critical  evaluation 
of all  the  data collected during  the clinical  investigation. - 96  -
MINIMUM  CRITERIA  FOR  THE  DESIGNATION  OF 
NQTIFIED  INSPECTION  BODIES 
· ··ANNEX  11 
1.  The  notified  body,  its Director  and  the  assessment  and  verification 
staff  shall  not  be  the  designer,  manufacturer,  supplier,  Installer 
or  user  of  the  devices  which  they  Inspect,  nor  the  authorized 
representatIve  of  any  of  these  persons.  They  may  not  be  dIrect I  y 
Involved  in  the  design,  construction,  marketing  or  maintenance  of 
the  devices,  nor  represent  the  parties  engaged  In  these  activities. 
This  in  no  way  precludes  the  possibility of  exchanges  of  technical 
Information  between  the manufacturer  and  the  body. 
2.  The  Inspection  body  and  Its staff must  carry out  the  assessment  and 
verification  operations  with  the  highest· degree  of  professional 
Integrity  and. the  requisite  competence  In  the  field  of  medical 
devices  and  must  be  free  from  alI  pressures  and  Inducements, 
particularly  financial,  which  might  Influence  their  Judgment  or  the 
results  of  the  Inspection,  especially  from  persons  or  groups  of 
persons with  an  Interest  In  the  results of  the  verifications. 
Should  the  notified  body  subcontract  specific  tasks  connected  with 
the  establishment· and  verification  of  the  facts,  it  must  first 
ensure  that  the  subcontractor  meets  the  provisions  of  the  Directive 
and,  In  particular,  of  this  Annex.  The  notified  body  shall  keep  at 
the  disposal  of  the  national  authorities  the  relevant  documents 
assessing  the  subcontractor's  qualifications  and  the  work  carried 
out  by  the subcontractor  under  this Directive. 
3.  The  notified  body  mus~  be  able  to  carry  out  all  the  tasks  assigned 
to  such  bodies  by  one  of  Annexes  2  to  6  and  for  which  It  has  been 
notified,  whether  these  tasks  are  carried out  by  the  body  itself or 
on  Its  responsibility.  In  particular,  It  must  have  the  necessary 
staff  and  possess  the  facilities  needed  to  perform  properly  the 
technical  and  administrative  tasks  entailed  In  assessment  and 
verification.  It  must  also  have  access  to  the  equipment  necessary 
for  the  ve~lflcations required. 4. 
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The  Inspection staff must  have: 
sound  vocational  training  covering  alI  the  assessment  and 
verification  operations  for  which  the  body  has  been 
designated; 
satisfactory  knowledge  of  the  rules  on  the  Inspections  which 
they  carry out  and  adequate experience of  such  Inspections; 
the  ability  required  to draw  up  the  certificates,  records  and 
reports  to  demonstrate  that  the  Inspections  have  been  carried 
out. 
5.  The  Impartiality  of  the  Inspection  staff  must  be  guaranteed.  Their 
remuneration  must  not  depend  on  the  number  of  Inspect Ions  carr led 
out,  nor  on  the  results of  the  Inspections. 
6.  The  body  must  take  out  civil  liability  Insurance,  unless  liability 
Is  assumed  by  the  State  under  the  national  law  or  the  Member  State 
Itself carries out  the  Inspections directly. 
7.  The  staff  of  the  Inspection  body  are  bound  to  observe  professional 
secrecy with  regard  to all  Information  gained  In  the  course of  their 
duties· (except  vis-A-vis  the  competent  administrative authorities of 
the  State  In  which  their  activities  are  carried  out)  under  this 
Directive or  any  provision of  national  law  putting  It  into effect. - 98  -
ANNEX  12 
CE  MARK  OF  CONFORMITY 
''!.,_  ...  ,  ..  , - 99  -
FICHE  FINANCIERE 
VOLET  1  :  IMPLICATIONS  FINANCIERES 
1 •  lntltul' de  l'actlon 
Proposition  de  directive  concernant  le  rapprochement  des 
legislations  des  Etats  membres  relatives  aux  dispositifs 
medicaux. 
article  B  5-300 
.a r t  i c I e  B  s-5 3 o· 
actions  relatives a  I 'achevement  du 
Marche  lnterleur,  depenses 
operationnel les 
actions  relatives  a  l'achevement  du 
Marche  lnterieur,  depenses  d'appul  et  de 
soutien. 
3.  Base  ''gale 
Article  100A  du  Traite  CEE 
4.  Description  de  !'action 
4.1.  Achevement  du  Marche  lnterieur  dans  le  secteur  des 
dispositifs  medicaux;  amelioration  de  Ia  protection  de 
Ia  sante  et  de  Ia  securite  des  patients  et  des 
uti I isateurs. 
En  sui van·t  I es  pr inc i pes  de  I a  Nouve I I e  Approche,  I a 
directive  harmonise  les  exigences  et  tes  procedures 
d'evaluatlon  de  ~onformite auxquel les  dolvent  repondre 
les  dlsposi.tifs  medicaux  tors  de  leur  mise  sur  le  marche 
et  de  leur  mise  en  service.  La  mise  en  oeuvre  efficace 
Imp I ique  aupres  de  Ia  Commission,  des  Etats  membres  et 
des  organismes  europeens  de  normalisation  CEN/CENELEC 
des  activites  dans  les  domaines  suivants  : 
etab 1 i ssement  des  normes  harmon i sees  par  I e 
CEN/CENELEC  faci I itant  Ia  preuve  de  Ia  conformite  aux 
e x I g en  c e s  essen  t i e I I e s  de  I a  d i r e c t. I v e , 
mise  en  place  par  les  Etats  membres  d'une 
Infrastructure  d'autorites  competentes  assurant  le 
contr&le  du  respect  de  Ia  direct·lve  ainsi  que  Ia 
designation  par  les  Etats  membres  des  organlsmes  de 
certification  charges  de  i·evaluation  de  Ia 
conformite, 
i 
II  ., 
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etabl lssement.et  gestlon  d'un  systeme  d'alerte 
permettant  aux  Etats  membres  de  prendre  de~ mesures 
de  protection suite! des  Incidents  lndesirables 
lntervenus  avec  des  dlsposltifs, 
elaboration  par  Ia  Commlsslo.n  des  I ignes ·di.rectrices 
utlles  A  l'appllcatlon  uniforme  de  Ia  directive 
- portant  sur  son  champ  d'appl tcatiQn .alnsl  que  sur  Ia 
classification  des  disposltifs, 
gestlon  des  procedures  concernant  Ia  classification 
des  dlspositlfs et  l'appllcatlon  de  Ia  clause  de 
sauvegarde  Imp I lqu~nt  le  recours  A  I 'avis  ~echnique 
des  experts,  . 
mIse  en  pI ace  d · une  __ base  europeenne -:de. donnees· 
portant  sur  Ia  certification  des  disposltlfs,  Ia 
c I a s_s 1  f I cat I on  ..  e t  -I e s  J nc l.de n t s  not I f.l e s- :dans  I e 
c.adre·  du  systeme  d-'alerte. 
4 • 2 .  D  u r e e  !  en v i ron  ,4-5  a n s ;  .  a c t i on  p on c t u e I I e .  .l e  m  on t a n t 
des  credits  al loues  pour  cette  action  sera  toutefois 
determine  chaque  annee  en-fonctlon  des  travaux  restant  A 
effectuer. 
4.3.  Population  concernee:  potentiellement,  !'ensemble  de  Ia 
population  communautaire  et  des  pays  tiers.· 
5.  Classification des  depenses 
5.1.  Oepenses  non  obi igatoires 
5. 2.:  85-300 
88-530 
credits  d.issocies 
credits  non  dissocies 
6~  Nature  des  depenses 
L'elaborat ion  des  no.rm·es  harm_onisees  par  le  CEN/CENELEC  est· 
couverte  par  une  contribution· financlere  de.  Ia  Communaute  et 
I'AELE  (part  du  -flnancement  lncombant  A  Ia  CE  ·:  86X,  a 
I 'AELE  :  14%).  Les  frais  restant  seront. couv.erts  par  les 
organismes  de  normalisation  et  les  part.ies  concernees 
< industrie,  organismes  de  certification etc). 
Le  flnancement  sera  octroye  moyenn~nt  des  bons  de  commande 
passes  ~n vertu  du  contrat-cadre  du  4  aoQt  1989  signe  avec  le 
CEN/CENELEC. 
La  mise  en  place  d'une  base  de  donnAes  necessltera  un 
f  i nan cement  sou  s.  forme  d · etude  de  f a I sa b II 1  t e  e t  de  p r e s t at 1  on 
de  ser.vi.ces .au  ~ours de  Ia  phase  de  demarrage. 
La·  four n I t u r e  des  a v I s  tech  n i Que s  n e cess  a i r e s  en  vue  des 
questions  specifiques  dans  le  cadre  de  Ia  gestion  courante 
sera  financee  par  de~ contiats  d'etude  et  de  prestation  de 
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7.  Incidence  flnancl~re sur  las  credits d'interventlon  (partie  B 
du  budget) 
a)  elaboration  des  normes  europeennes  <CD> 
1.  Mode  de calcul 
Le  flnan~ement sera  determine  en  fonct.lon  des  travaux  A 
confler  aux  contractants.  I I  sera  calcule  sur  Ia  base  de 
l'unite  "homme/mois",  qui  s'eleve  actuel lement  a 
8.000  ECU. 
Le  nombre.de  normes  harmonlsees  necessalres  Jusqu'a  fin 
1996  est  de  360.  La  contribution  de  Ia  Commission  est 
estlmee  l  6,25  hommes/mols  par  norme; 
Frais  totaux  :  1.875  hommes/mols.  solt  15  mlo  ECU 
2.  L'echeancier indicatif des credits  pourrait  ~tre  le 
suivant  : 
Credits  d'engagement 
(1 .000  ECU) 
Credits  de  paiement 
(1.000  ECU) 
1992  ...... 1.500  1.000 
2.000 
4.000 
5·.ooo 
3.000 
1993  .......  4.000 
1994  ...... 5.000 
1995  ...... 4.500 
1996  .  . . . . .  p.m . 
------
15.000  15.000 
Le  niveau  des  credits  !  partl~  de  1992  sera  fixe  par  Ia 
procedure  budgetaire  annuel le  dans  le  cadre  des 
contraintes  fixees  par  les  Perspectives  flnancieres 
post  92. 
Pour  1992,  le  montant  global  (mini-budgets  compris)  est 
inclus  dans  le  chlffre  total  des  dApenses  de  -
No-tification,  reconnaissance  mutuelle,  harmonisation  des 
legislations  techniques,  normalisation  et  rectification 
et  essais  (33.153.000)  de  Ia  fiche  financiere  globale 
des  postes  85-300  et  88-530. 
b)  autres  mesures  financees  par  le  mini-budget 
conformement  A  Ia  decision  de  Ia  Commission  du  22.5.1990 
sur  tes  mini-budgets 
frais  d'experts  :  450!  500  ECU  par  expert,  par  Jour 
rr!.! 
*  1992  30  X  450  ECU  ..............  13.500 
*  1993  30  X  450  ECU  .............  1'3.500 
*  1994  30  X  450  ECU  ..............  13.500  ..  1995  20  X  500  ECU  ..............  10.000 
*  1996  20  X  500  ECU  .............  10.000 
-------
TOTAL  (1992-1996)  60.500 _,.. 
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. frais  pour  Ia  mise  en  place. et  le  demarrage  de.  Ia  base 
de  donnees,  A repartlr  en  trois  tranches  sur  les  annees 
1992  a 1994 
*  1992 
*  1993 
*  1994 
................................... 
...............................  • ... 
.............................  ;. ...... 
TOTAL  (1992~1994) 
200.000 
200.000 
100.000 
500.000 
a.  Dispositlons-antl-fraude  pr~vues dans.  Ia  proposition  d•actiQn? 
Le  contrat-cadre  vise  sous .le  point  6.  prevoit  un 
6chelonnement  des  palements  en  fonctlon  des  progres  des 
travaux,  alnsi  QUe  Ia  possibillte  d'un  audit  par  Ia  Commission 
pu  Ia  Cour  des  Comptes. 
VOLET  2  :  DEPENSES  ADMINSTRATIVES  (partie  A  du  budget) 
L'action  proposee  impl !Que  une  augmentation  du  personnel  statutaire 
affecte  a  Ia  gestion  de  Ia  directive.  Les  procedures  declslonnelles 
portant  sur  Ia  classification  des  disposltifs  et  sur  Ia  clause  de 
sauvegarde,  le  suivi  de  Ia  normalisation  europeenne  presupposent 
!'existence d'effectifs  pouvant  etablir  des  analyses  et  avis 
technico-JuridiQues  et  en  organiser  Ia  gestion  administrative. 
Les  besoins  en  personnel  sont  a pourvoir,  solt  par  vole  de 
redeplolement  interne,  soit  par  decision  de  Ia  Comm~ssion 
allocation  ressources  dans  le  cadre  de  Ia  procedure  budgetaire.  lis 
sont  estlmes.  pour  l'unite  111.0.4,  a partir  de  1992 a: 
- 1  A 
- 1  B 
soit  environ  200.600  E~U.  a raison  de  100.000  ECU  en  moyenne  par 
personne  et  par  an. 
VOLET  3  :  ELEMENTS  D'ANALYSE  COUT-EFFICACITE 
1.  Objectifs et  coherence  avec  Ia  programmatlon  flnancl~re 
La  directive  de  type  Nouvelle  Approche  s'inscrlt  dans  le  cadre 
de  I 'achevement  du  ~arche  Inter leur.  Le  renvoi  aux  normes 
harmonisees  fait  partie  de  l'action  pluriannuelle  de  Ia 
Commission  QUi  conslste  a soutenir  le  renforcement  et 
I 'elargissement  de  Ia  normal lsation  europeenrie. 
L'actlon  est  prevue  dans  Ia  programmatlon  flnanci6re  de  Ia 
DG  I I I. - 103 -
2.  Justification  de  l"actlon 
Les  divergences  dans  les  systemes  nationaux  en  ce  qui  concerne 
les  exigences  pour  les  produits  et  les  procedures  relatives a 
Ia  mise  sur  le  marche  entratnent  un  gaspi I I age  enorme  de 
ressources  humaines  et  flnancieres  a charge  des  fabrlcants  et 
des  Etats  membres. 
Les  procedures  communautaires  petmettront  d'evlter  Ia 
repetition  multi.ple  des  procedur~s visant  le  m~me objet.  De 
plus.  les  exigences  harmonisees  permettront  a  I' Industria  de 
rea 1 1  s e r  des  e con  o.m 1  e s  s u r  1  e  p r 1 x  p a r  u n 1 t e  de  p r o d u c t  1  on •  c: e 
qui  pourra  mAme  avoir  un  effet  beneflque  sur  les  depenses  a 
charge  des  systemes  de  sante  publ lque. 
Quant  a  I 'harmonisation  des  normes,  !'action  vise  a mettre  en 
commun  les  ressources  et.  de  ce  fait,  a eviter  Ia 
multiplication  des  depenses  pour  !'ensemble  des  Etats  membres. 
Globalement,  les  ressources  requises  a  imposer  au  budget 
communautaire  ne  represent~nt qu'une  part  mineure  par  rapport 
a  Ia  total ite  des  ressources  qui.  de  Ia  part  des  Etats  membres 
et  des  parties  concernees,  seront  allouees  dans  Ia  suite  de 
!'action  au  benefice  commun. 
3.  SUIVI  et  evaluation  de  l''ac·tlon 
3.1.  Indication des  performances 
degre  d'harmonisation  au  plan  de  Ia  normalisation 
(nombre  de  normes), 
nombre  de  certifications  effectuees, 
nombre  de  rapports  notifies  sur  des  incidents 
indesirables, 
nombre  de  procedures  de  clause  de  ~auvegarde. 
3.2.  Modalit~s des  ~valuations  : 
rapports  d'etat  des  progres  periodiques  sur  Ia 
normalisation  dans  le  cadre  de  Ia  directive  du 
Consei I  83/189/CEE  ayant  au  minimum  un  caractere 
annue I ; 
echanges  de  vues  dans  un  Comite  sectorial 
"dlspositifs  medicaux" . 
. 3.3.  Principaux facteurs d'incertitude 
Ia  designation  des  organlsmes  de  certification  par 
les  Etats  membres  se  fait  sur  une  base  facultative  et 
de  manlere  decentral isee, 
!'assurance  d'une  application  homogene  d'Un  tel 
systeme  presuppose,  aussi  bien  aupres  des  Etats 
membres  que  sur  le  plan  communautaire,  Ia 
disponibilite  d'interfaces  assurant  le  fonctionnement 
des  procedures. - 104  -
Fiche  d'$valuatlon  d' Impact 
Impact  de·  Ia  propositi~n  s~r  les  entreprtses et,  en 
particulier,  sur  les  petites et  moyennes  entreprlses 
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LA  PROPOSITION 
.1.  Compte  tenu  du  prlncipe  de  subsldlarit6,  pourquol  une 
.I  6 g 1 s 1 a t  1 o n  c o m  111  u n a u t a I r e  e s t - e I I e  n 6 c e s s a I r e  d a n s  c e 
domalne  et  quels  sont  ses  prlncipaux  objectlfs?  · 
Les  reglementations  nationales  relatives  a  Ia  mise  sur  le 
marche  et  Ia  mise  en  service  d·e.s~··disposltlfs  medlcaux 
presentent  un  tel  degre  de  divergences  substantial les, 
qu•une  I ibre  circulation  dans  Ia  Communaut~ n'est pas 
assuree.  l'harmonisation  des  exigences  et  des  procedures 
d~evaluation de  Ia  conformite  auxquel les  doivent· repondre 
les  dispositifs  medlcaux  pour  assurer  Ia  protection  des 
patients,  utilisateurs  et  tiers est,  des  lors,  le  seul  moyen 
pour  achever  le  marche  interieur  dans  ce  secteur. 
IMPACT  SUR  LES  ENTREPRISES 
2.  Qui  sera  affect6  par  Ia  proposition? 
secteurs  d'entreprises  :  tout  fabricant  de  dispositifs 
medica~x  (a  I 'exception  des  dispositifs  implantables 
actifs,  tels  que  des  stimulateurs  cardiaques  ~insi  que 
des  dispositifs destines  au  diagnostic  in-vJtro), 
exemples:  appareils  electromedicaux,  produits  a usage 
unique,  materiaux  et  protheses  dentaires,  protheses 
orthopediques,  instruments,  etc 
tallies  des  entreprises  :  toute  tal lie  .•  y  comprls  les 
multinationales et  las  PME 
zones  geographigues  particulieres  d'implantatlon  aucune . - 105  -
3.  Quelles  1esures  les  entreprlses  devront-elles  prendre  pour 
se  contor1er  A  Ia  proposition? 
A partir  de  l'appllcatlon·totale  de  Ia  directive,  c'est-~-
dire  le  1er .Julllet·1997: 
Ia  conception  et  Ia  fabrication  des  produits  devront 
r~pondre  aux  exlgences  de  Ia  directive, 
les  fabrlcants  ou  leurs  mandataires  devront  sulvre  les 
procedures  d'evaluation  de  conformite  prevues. 
Au  cours  d'une  p~riode de  trois  ans  ~partir de. Ia  premiere 
application  de  Ia  directive  (entre  juin  1994  et  Juln  1997). 
les  fabrlcants  pourront.  solt  continuer~ appllquer  les 
l~gislations natlonales  preexlstantes,  solt  se  conform•r  au 
regime  harmonise. 
Quant  aux  procedures  d'evaluatlon  de  conformrte,  les 
fabrlcants  pourront  choislr,  en  cas  d'lnterventlon  d'une 
tierce  partie,  entre  trois  ou  quatre  procedures 
alternativement  appl lcables. 
Les  dispositions  transitolres ainsi  que  le  cholx  pour  les 
fabrlcants  entre  piusieurs  procedures  d'evaluatlon  de  Ia 
conformite  devront  faciliter  Ia  transition  v.ers  le  r~glme 
harmonise. 
4.  Duels  effets  6conomlques-la  proposition  est-elle  susceptible 
d'avolr? 
sur  l'emplol:  aucun  effet slgnlficatif  n'est  escompte. 
sur  les  lnvestissements  et  Ia  cr~ation  de  nouvelles 
entreprises  :  Ia  dtrective  peut  avoir  comma  effet, 
notamment  en  ce  qui  concerne  les  dispositifs  medlcaux 
presentant  un  risque  eleve,  qu'une  partie  des  entreprises 
doivent  adapter  leurs  procedes  de  fabrication,  de  sorte  ~ 
permettre  unequal ite  de _production  elevee  et  constante. 
Or,  ces  investlssements  renforceront  Ia  comp~tltlvlte des 
entreprises. 
sur  Ia  competltivite  des  entreprises  :  1 'action  proposee 
faci I itera  1 'acces  ~  un  marche  de  dimension 
communautaire.  Cette  perspective  ouvrlra  de  nouveaux 
horizons  aux  entreprlses  de  tai I le  plus  modeste  qui  ne 
dlsposent  pas  de  fi I iales  dans  chaque  Etat  membre  pour 
traiter  directement  avec  les  autorites  nationales 
competentes.  II  faut  egalement  soul igner  que  les 
en~reprises devront,  de  ce  fait,  f~ire  face~ une 
Intensification  de  Ia  concurrence. 
5.  La  proposition  contlent-el le  des  mesures  vlsant  A  tenlr 
compte  de  Ia  situation  sp6clfique  des  petites  et  1oyennes 
entreprises? 
Non. 
···~. F 
- 106 -
CONSULTATION 
Pour  prAparer  cette  proposition,  Ia  Commission  a.  organlsA,  depui~ 
1989,  a~ molns  cinq  rAunlons  rassemblant  les  experts 
gouvernementaux  et  les  fAdArations  professionnel tes.  De  plus,  de 
multiples  rAunions  bi latArales  avec  les  feqerations  sur  des 
aspects  speclfiques  ont  eu  I ieu. 
Ont  ete  consultees  : 
les  associations  europeeMn&s  de 'l'industrie  des  dlspositifs 
medicaux. 
les  associations  des  utilisateurs,  notamment  des  medeclns  et 
des  pharmaciens. 
La  C6mmisslon  a,  dans  une  large  mesure,  tenu  compte  des 
commentaires  recus  lors  de  Ia  consultation.  Les  milieux 
I n t e r esse  s ,  y  com p r I s  I e s  fed  e r a t  i on s  I n d us t r I e I I e s ,  on t 
principalement  supporte  l'approche.suivie  dans  t~ proposition . 
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/. I  .. 
ISSN 0254-1475 
COM(91) 287 final 
DOCUMENTS 
EN  06 
Catalogue number : CB-CQ-91-356-EN-C 
"  Office for Official Publications of the European Communities 
L~98S  LUxembourg 
- . 
.  ISBN 92-77-74963-6 